var title_f27_46_28384="TSC angiofibromas";
var content_f27_46_28384=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angiofibromas of the face in a child with tuberous sclerosis complex",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28384=[""].join("\n");
var outline_f27_46_28384=null;
var title_f27_46_28385="Billroth II anatomy";
var content_f27_46_28385=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60887&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60887&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Billroth II gastrectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 431px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the relationship between the afferent and efferent limbs of the gastrojejunostomy and the ampulla of Vater following Billroth II reconstruction. During endoscopic retrograde cholangiopancreatography, the landmarks of the ampulla are inverted by 180&ordm; compared to their location in native anatomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28385=[""].join("\n");
var outline_f27_46_28385=null;
var title_f27_46_28386="Technique of below-knee amputation with skew flap";
var content_f27_46_28386=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F52849&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F52849&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    Technique of below-knee amputation with skew flap",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 679px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28386=[""].join("\n");
var outline_f27_46_28386=null;
var title_f27_46_28387="Perforating dermatosis 4";
var content_f27_46_28387=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acquired reactive perforating dermatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28387=[""].join("\n");
var outline_f27_46_28387=null;
var title_f27_46_28388="CMML peripheral smear";
var content_f27_46_28388=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Chronic myelomonocytic leukemia peripheral smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic myelomonocytic leukemia, peripheral blood. Monocytes are increased and show a higher nucleus:cytoplasm ratio compared with normal cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Farhi DC. Myelodysplastic syndromes. In: Pathology of Bone Marrow and Blood Cells, 2nd ed, Farhi DC (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28388=[""].join("\n");
var outline_f27_46_28388=null;
var title_f27_46_28389="Coryneform bacteria";
var content_f27_46_28389=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Corynebacterium matruchotii",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Funke G, Bernard K. Coryneform Gram-positive rods. In: Manual of Clinical Microbiology, Murray PR, Baron EJ, Jorgenson JH, et al (Eds), 9th ed, Vol 1, ASM Press, Washington, DC, 2007. p. 488. Copyright &copy; 2007 American Society for Microbiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28389=[""].join("\n");
var outline_f27_46_28389=null;
var title_f27_46_28390="Greatly enlarged liver - low power";
var content_f27_46_28390=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    A 58-year-old woman with longstanding rheumatoid arthritis, an elevated serum alkaline phosphatase, and a greatly enlarged liver (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The few remaining hepatocytes (red, arrow) are compressed by the blue staining glycoproteins.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28390=[""].join("\n");
var outline_f27_46_28390=null;
var title_f27_46_28391="Adrenal steroid biosynthesis";
var content_f27_46_28391=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Adrenal steroid biosynthesis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/46/28391/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/46/28391/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/46/28391/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/46/28391/contributors\">",
"     Andre Lacroix, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/46/28391/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/46/28391/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/46/28391/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary action of corticotropin (ACTH) on the adrenal cortex is to increase cortisol secretion by increasing its synthesis; intraadrenal cortisol storage is minimal [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/1\">",
"     1",
"    </a>",
"    ]. The major adrenal steroid hormones are synthesized in different areas of the adrenal cortex: glucocorticoids (particularly cortisol), androgens, and estrogens in the zona fasciculata and reticularis; and aldosterone in the zona glomerulosa. An appreciation of these pathways serves as the basis for understanding the different forms of congenital adrenal hyperplasia (CAH) and isolated hypoaldosteronism in which there are defects in the function of the enzymes involved in adrenal steroid hormone synthesis.",
"   </p>",
"   <p>",
"    The steps involved in the production of adrenal steroids will be reviewed here. The metabolism of adrenal steroids is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/1/9240?source=see_link\">",
"     \"Metabolism of adrenal steroids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTH ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACTH acts by binding to a specific cell-surface receptor, the melanocortin receptor-2 (MCR-2) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/2\">",
"     2",
"    </a>",
"    ]. ACTH up-regulates expression of these receptors, thereby increasing the steroidogenic response to further ACTH stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/3\">",
"     3",
"    </a>",
"    ]. ACTH binding to its receptors activates adenylyl cyclase, increasing cyclic AMP (cAMP) production, which in turn stimulates cAMP-dependent protein kinase (protein kinase A) and phosphorylation of a number of proteins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CHOLESTEROL SUBSTRATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholesterol is the substrate for the synthesis of all steroid hormones. The cells of the adrenal cortex can either take up cholesterol from the circulation or synthesize cholesterol de novo from acetate. In humans, cholesterol for adrenal steroidogenesis is taken up from the bloodstream as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum low-density lipoproteins (LDL) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/4-6\">",
"       4-6",
"      </a>",
"      ], which are delivered to the interior of adrenocortical cells via specific cell surface receptors for LDL [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/7,8\">",
"       7,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      High-density-lipoprotein (HDL) cholesterol is also an important source of substrate for human adrenal steroidogenesis. In patients in whom delivery of LDL cholesterol to the adrenal is impaired, basal adrenal steroidogenesis is normal. Patients with abetalipoproteinemia, a heritable deficiency of apolipoprotein B production and no LDL in serum, and patients with familial hypercholesterolemia caused by defects in the LDL receptor system have normal basal cortisol production [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/9,10\">",
"       9,10",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A receptor system for HDL, SR-BI (scavenger receptor, class B, type I) receptor, transfers HDL cholesterol into cells without endocytosis of the entire lipoprotein particle, as occurs with LDL [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/11\">",
"       11",
"      </a>",
"      ]. SR-B1 knockout mice have lipid-depleted adrenocortical cells and high serum HDL cholesterol concentrations [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/12\">",
"       12",
"      </a>",
"      ]. The human homolog of SR-B1, called CLA-1, is expressed in liver and steroidogenic cells and transfers HDL cholesterol into cultured adrenal cells [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Expression of SR-B1 is regulated as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      It is stimulated or positively regulated by activation of adenylyl cyclase, the transcription factor, steroidogenic factor-1 (SF-1), sterol regulatory element-binding protein 1a (SREBP-1a), and cofactors such as promoter-specific transcription factor (Sp1). Patients heterozygous for inactivating SF-1 mutations have adrenal insufficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      It is suppressed by the intracellular level of cholesterol and negatively regulated by the dose-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene 1 (DAX-1) transcription factor [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"      <span class=\"nowrap\">",
"       Dax-1(-/Y)",
"      </span>",
"      mice have normal basal serum corticosterone levels and have greater corticosterone responses to ACTH than wild-type mice [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CORTISOL BIOSYNTHESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Four distinct cytochrome P450 enzymes are involved in adrenal corticosteroid biosynthesis. They are members of a large family of cytochrome P450 oxidative enzymes, so named because they have a characteristic 450 nm absorbance maximum when reduced with carbon monoxide. These enzymes serve a variety of biologic functions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/19\">",
"     19",
"    </a>",
"    ]. They transfer electrons from NADPH, provided by an electron-transport protein intermediary, to molecular oxygen with concomitant oxygenation of a number of substrates. The nomenclature of these enzymes has been changed as a result of insights gained from molecular cloning. The current terminology, previous designation, and common names are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef55287 \" href=\"UTD.htm?19/20/19787\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The substrates for the steroidogenic P450 enzymes are carbon atoms of the four ring structures of cholesterol (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Each enzymatic step in cortisol biosynthesis is compartmentalized within the cell by virtue of the subcellular localization of the enzyme involved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pregnenolone synthesis by CYP11A1",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate-limiting process in steroidogenesis is the transport of free cholesterol through the cytosol to the inner mitochondrial membrane, the site of the cholesterol side-chain cleavage enzyme (CYP11A1) that catalyzes the first step in steroidogenesis (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cholesterol transport into mitochondria is mediated by a protein designated StAR (steroidogenic acute regulatory protein) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/20-22\">",
"       20-22",
"      </a>",
"      ]; in the absence of this protein, steroidogenesis is severely impaired [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Basal and cAMP-stimulated StAR expression are increased by SF-1 acting in concert with transcription factor Sp1 [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another multimeric protein complex, the peripheral benzodiazepine receptor (PBR), is also required for transfer of cholesterol into the mitochondrion [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/24\">",
"       24",
"      </a>",
"      ]. ACTH does not regulate expression of this protein.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Within mitochondria, pregnenolone is derived from cholesterol by removal of the side chain at C20 catalyzed by a single enzyme derived from the CYP11A1 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The electrons transferred by CYP11A1 during the side-chain cleavage reaction are provided through an electron transport system comprised of adrenodoxin that exists in a soluble form in mitochondria, and adrenodoxin reductase, a mitochondrial membrane-bound flavoprotein. Adrenodoxin reductase accepts electrons from an NADPH-dependent cytochrome P450 reductase and transfers them to adrenodoxin, which serves as a shuttle to deliver reducing equivalents to various P450 enzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Conversion of pregnenolone to progesterone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newly synthesized pregnenolone is converted to progesterone by dehydrogenation of the 3-hydroxyl group of pregnenolone and isomerization of the double bond at C5 (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    ). These reactions are catalyzed by 3-beta-hydroxysteroid dehydrogenase II, a membrane-associated enzyme that is expressed only in the adrenals and gonads [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Progesterone to 17-alpha-hydroxyprogesterone",
"    </span>",
"    &nbsp;&mdash;&nbsp;CYP17 is a microsomal enzyme that catalyzes both hydroxylation at C17 of progesterone or pregnenolone (17-alpha-hydroxylase activity) and cleavage of the residual 2-carbon side chain at C17 (17,20-lyase activity) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The dual function of CYP17 allows steroidogenesis to be directed to several different pathways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      17-alpha-hydroxylated substrates with the side chain intact are glucocorticoid precursors.",
"     </li>",
"     <li>",
"      Generation of C19 steroids by both 17-alpha-hydroxylase and 17,20-lyase activities directs substrate towards androgen and estrogen synthesis (",
"      <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In the zona glomerulosa, which lacks either form of CYP17 activity, pregnenolone is converted into aldosterone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whether a steroid molecule undergoes both 17-alpha-hydroxylation and lysis of the 17,20 bond appears to depend upon the availability of electrons from a flavoprotein distinct from mitochondrial adrenodoxin. This protein also supplies electrons to CYP21A1, the other microsomal P450 enzyme [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     17-alpha-hydroxyprogesterone to 11-deoxycortisol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both progesterone and 17-alpha-hydroxyprogesterone are 21 hydroxylated by a single CYP21A2 enzyme (21-hydroxylase) located in the smooth endoplasmic reticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/30\">",
"     30",
"    </a>",
"    ]. There are two related CYP21 genes on chromosome 6p21.3 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/31\">",
"     31",
"    </a>",
"    ], but only one is active [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Conversion of 11-deoxycortisol to cortisol",
"    </span>",
"    &nbsp;&mdash;&nbsp;The last step in cortisol biosynthesis is the 11-beta-hydroxylation of 11-deoxycortisol, a reaction catalyzed by the mitochondrial enzyme CYP11B1. Like CYP11A1, the other P450 enzyme of the inner mitochondrial membrane, CYP11B1 receives electrons from NADPH via adrenodoxin reductase and adrenodoxin [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CYP11B1 is nearly identical to the CYP11B2 enzyme responsible for the terminal steps of aldosterone synthesis, except that it lacks the ability to convert corticosterone to aldosterone. CYP11B1 is more closely related to CYP11A1 than to the microsomal P450 enzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. CYP11B1 expression is increased by cAMP and steroidogenic factor-1 (SF-1) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ALDOSTERONE BIOSYNTHESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progesterone is also the substrate for mineralocorticoid synthesis. In the zona glomerulosa progesterone is hydroxylated at C21 by CYP21A2 to yield deoxycorticosterone. All three terminal steps in the conversion of this intermediate to aldosterone (11-beta-hydroxylation, 18-hydroxylation, and 18-methyl oxidation) are catalyzed by a single mitochondrial P450 enzyme, CYP11B2 (aldosterone synthase, P450c11as) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. The human CYP11B2 is encoded by a gene closely related to CYP11B1 (11-beta-hydroxylase), with over 90 percent homology at the protein level. The CYP11B2 gene is also located on chromosome 8q24.3, near the CYP11B1 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The zona glomerulosa is well adapted for the production of aldosterone.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It has a low concentration of CYP 17 (17-hydroxylase), the enzyme that directs substrate along the pathways to cortisol and androgen synthesis.",
"     </li>",
"     <li>",
"      It is the only adrenocortical zone that has the enzyme required for the sequential conversion of deoxycorticosterone to aldosterone [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The restriction of CYP11B2 (aldosterone synthase) expression to the zona glomerulosa is very important physiologically. Expression of the gene in the zona fasciculata would render aldosterone production subject to regulation by ACTH. Such a complication occurs in patients with glucocorticoid-remediable aldosteronism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22615?source=see_link\">",
"     \"Familial hyperaldosteronism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In normal subjects angiotensin II and a small rise in the serum potassium concentration are the primary stimuli to aldosterone release. SF-1, which stimulates CYP11B1 expression, does not alter expression of CYP11B2 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/36\">",
"     36",
"    </a>",
"    ]. Expression of StAR, which increases aldosterone synthesis, is stimulated by increased intracellular calcium concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2376?source=see_link\">",
"     \"Chapter 6C: Aldosterone\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ADRENAL ANDROGEN BIOSYNTHESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Steroids with 19 carbon atoms and androgenic activity are synthesized by the adrenals. In fact, dehydroepiandrosterone (DHEA) and DHEA sulfate are the most abundant products of the adrenal glands. They are formed in the zona reticularis, which has no type 2 3-beta-hydroxysteroid dehydrogenase [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/40\">",
"     40",
"    </a>",
"    ], from 17-alpha-hydroxypregnenolone by the 17,20-lyase activity of CYP17 (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Androstenedione, another weak androgen, is produced by side-chain cleavage of 17-alpha-hydroxyprogesterone by P450c17 and is subsequently converted to testosterone by 17-ketosteroid reductase, mainly in peripheral tissues. There is minimal synthesis of testosterone in the adrenal gland. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=see_link\">",
"     \"Adrenal hyperandrogenism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several extraadrenal factors have been proposed as stimuli of adrenal androgen secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/41\">",
"     41",
"    </a>",
"    ]. These factors include prolactin, for which there are abundant receptors on adrenocortical cells. In women with prolactinomas, serum DHEA sulfate concentrations are weakly correlated with serum prolactin concentrations.",
"   </p>",
"   <p>",
"    Adrenal androgen secretion is reduced in patients receiving T-lymphocyte-suppressive drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/42\">",
"     42",
"    </a>",
"    ]. T lymphocytes are present in the zona reticularis and form direct cell-cell contact with zona reticularis steroidogenic cells, which constitutively express major histocompatibility complex (MHC) class II molecules [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/43\">",
"     43",
"    </a>",
"    ]. Lymphocytes increase DHEA secretion by adrenal cells fourfold in vitro, an effect greater than that of maximally stimulating ACTH concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ACUTE AND CHRONIC ACTIONS OF ACTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of ACTH on steroidogenesis can be divided into acute effects, which occur within minutes, and chronic effects, which occur in hours or days [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The acute effect of ACTH is to increase conversion of cholesterol to delta-5-pregnenolone, the initial and rate-limiting step in cortisol biosynthesis (",
"      <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/44\">",
"       44",
"      </a>",
"      ], by activation of CYP11A1. This response requires hormonally-induced synthesis and phosphorylation of StAR for translocation of cholesterol from the mitochondrial outer to inner membrane [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/22,45\">",
"       22,45",
"      </a>",
"      ]. The chronic effects of ACTH involve increased synthesis of most of the enzymes of the steroidogenic pathway and more general actions on adrenocortical cell protein, RNA and DNA synthesis, and cell growth [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/19\">",
"       19",
"      </a>",
"      ]. In bovine adrenocortical cells, ACTH increases the rate of synthesis of all steroidogenic CYP enzymes, including CYP11A1, CYP17, CYP21A2, and CYP11B1 [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/46\">",
"       46",
"      </a>",
"      ], plus the electron-transport protein adrenodoxin [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/47\">",
"       47",
"      </a>",
"      ] and adrenodoxin reductase [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      ACTH also increases the synthesis of other proteins required for steroidogenesis. These include the low-density lipoprotein (LDL) and high-density lipoprotein (HDL) receptors [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/48\">",
"       48",
"      </a>",
"      ], adrenodoxin [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/48\">",
"       48",
"      </a>",
"      ], and sterol-carrier protein (SCP2) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      ACTH action on glomerulosa cells is complex. It initially stimulates and later suppresses aldosterone synthase gene expression.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H239059580\">",
"    <span class=\"h1\">",
"     METABOLISM OF ADRENAL STEROIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral and target tissue metabolism of adrenal steroids is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/1/9240?source=see_link\">",
"     \"Metabolism of adrenal steroids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OVERVIEW OF CAH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inherited defects in the enzymatic steps of cortisol biosynthesis result in a group of syndromes termed congenital adrenal hyperplasia (CAH) (",
"    <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"     figure 1",
"    </a>",
"    ). These disorders are all inherited as autosomal recessive traits [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28391/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/9/24726?source=see_link\">",
"     \"Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11034?source=see_link\">",
"     \"Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The resulting decrease in cortisol production causes an increase in the secretion of ACTH, thereby stimulating the production of adrenal steroids up to and including the substrate for the defective enzyme. The clinical manifestations reflect one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Impaired synthesis of cortisol.",
"     </li>",
"     <li>",
"      In some cases, impaired synthesis of aldosterone.",
"     </li>",
"     <li>",
"      Excessive synthesis of precursor steroids due to the increase in ACTH secretion. This can result in increases in androgenic hormones (which can cause virilization) and in deoxycorticosterone (which has mineralocorticoid activity and can cause hypertension).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    What follows is a brief review of the consequences of the different enzymatic defects, each of which is discussed in detail elsewhere (",
"    <a class=\"graphic graphic_table graphicRef76865 \" href=\"UTD.htm?39/0/39949\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Salt wasting and hyperkalemia, resulting from mineralocorticoid deficiency, occur in CYP21A2 deficiency, 3-beta-hydroxysteroid dehydrogenase deficiency, and congenital lipoid adrenal hyperplasia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11034?source=see_link\">",
"       \"Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35641?source=see_link\">",
"       \"Uncommon causes of congenital adrenal hyperplasia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Similar abnormalities occur as the sole finding with defects in aldosterone synthase; cortisol synthesis is intact in these disorders. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=see_link\">",
"       \"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypertension and frequently hypokalemia due to excess deoxycorticosterone is the major abnormality in CYP17 (17-alpha-hydroxylase) and CYP11B1 deficiencies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=see_link\">",
"       \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35641?source=see_link\">",
"       \"Uncommon causes of congenital adrenal hyperplasia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Virilization of female fetuses (female pseudohermaphroditism) or hirsutism and virilization of females later in life occurs in CYP21A2 (21-hydroxylase) deficiency and in CYP11B1 (11-beta-hydroxylase) deficiency because of increased androgen synthesis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11034?source=see_link\">",
"       \"Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=see_link\">",
"       \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypogonadism and male pseudohermaphroditism can be a consequence of CYP17 deficiency, 3-beta-hydroxysteroid dehydrogenase deficiency, or congenital lipoid adrenal hyperplasia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35641?source=see_link\">",
"       \"Uncommon causes of congenital adrenal hyperplasia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H239059600\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary action of corticotropin (ACTH) on the adrenal cortex is to increase cortisol secretion by increasing its synthesis; intraadrenal cortisol storage is minimal. The major adrenal steroid hormones are synthesized in different areas of the adrenal cortex:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Glucocorticoids (particularly cortisol), androgens, and estrogens in the zona fasciculata and reticularis",
"     </li>",
"     <li>",
"      Aldosterone in the zona glomerulosa",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cholesterol is the substrate for the synthesis of all steroid hormones. The cells of the adrenal cortex can either take up cholesterol from the circulation or synthesize cholesterol de novo from acetate (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Cholesterol substrate'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Four distinct cytochrome P450 enzymes are involved in adrenal corticosteroid biosynthesis (",
"      <a class=\"graphic graphic_table graphicRef55287 \" href=\"UTD.htm?19/20/19787\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The steps of cortisol biosynthesis are shown in the figure (",
"      <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Cortisol biosynthesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The steps of aldosterone and adrenal androgen biosynthesis are reviewed above (",
"      <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Aldosterone biosynthesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Adrenal androgen biosynthesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inherited defects in the enzymatic steps of cortisol biosynthesis result in a group of syndromes termed congenital adrenal hyperplasia (CAH) (",
"      <a class=\"graphic graphic_figure graphicRef70372 \" href=\"UTD.htm?0/7/123\">",
"       figure 1",
"      </a>",
"      ). These disorders are all inherited as autosomal recessive traits. An overview of the different forms of CAH is found above (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Overview of CAH'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/1\">",
"      Dickerman Z, Grant DR, Faiman C, Winter JS. Intraadrenal steroid concentrations in man: zonal differences and developmental changes. J Clin Endocrinol Metab 1984; 59:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/2\">",
"      Cone RD, Mountjoy KG. Molecular genetics of the ACTH and melanocyte-stimulating hormone receptors. Trends Endocrinol Metab 1993; 4:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/3\">",
"      Penhoat A, Lebrethon MC, B&eacute;geot M, Saez JM. Regulation of ACTH receptor mRNA and binding sites by ACTH and angiotensin II in cultured human and bovine adrenal fasciculata cells. Endocr Res 1995; 21:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/4\">",
"      Borkowski AJ, Levin S, Delcroix C, et al. Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation. J Clin Invest 1967; 46:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/5\">",
"      Bolt&eacute;, E, Coudert, S, Lefebvre, Y. Steroid production from plasma cholesterol. II. In vivo conversion of plasma cholesterol to ovarian progesterone and adrenal C19 and C21 steroids in humans. J Clin Endocrinol Metab 1967; 38:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/6\">",
"      Gwynne JT, Strauss JF 3rd. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982; 3:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/7\">",
"      Faust JR, Goldstein JL, Brown MS. Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells. J Biol Chem 1977; 252:4861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/8\">",
"      Goldstein JL, Anderson RG, Brown MS. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979; 279:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/9\">",
"      Illingworth DR, Kenny TA, Orwoll ES. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J Clin Endocrinol Metab 1982; 54:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/10\">",
"      Illingworth DR, Lees AM, Lees RS. Adrenal cortical function in homozygous familial hypercholesterolemia. Metabolism 1983; 32:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/11\">",
"      Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/12\">",
"      Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A 1997; 94:12610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/13\">",
"      Imachi H, Murao K, Sato M, et al. CD36 LIMPII analogous-1, a human homolog of the rodent scavenger receptor B1, provides the cholesterol ester for steroidogenesis in adrenocortical cells. Metabolism 1999; 48:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/14\">",
"      Murao K, Terpstra V, Green SR, et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997; 272:17551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/15\">",
"      Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000; 67:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/16\">",
"      Cao G, Zhao L, Stangl H, et al. Developmental and hormonal regulation of murine scavenger receptor, class B, type 1. Mol Endocrinol 1999; 13:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/17\">",
"      Lopez D, Shea-Eaton W, Sanchez MD, McLean MP. DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1. Endocrinology 2001; 142:5097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/18\">",
"      Babu PS, Bavers DL, Beuschlein F, et al. Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 2002; 143:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/19\">",
"      Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/20\">",
"      Lin D, Sugawara T, Strauss JF 3rd, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267:1828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/21\">",
"      Waterman MR. A rising StAR: an essential role in cholesterol transport. Science 1995; 267:1780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/22\">",
"      Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996; 17:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/23\">",
"      Sugawara T, Saito M, Fujimoto S. Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology 2000; 141:2895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/24\">",
"      White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/25\">",
"      Chung BC, Matteson KJ, Voutilainen R, et al. Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc Natl Acad Sci U S A 1986; 83:8962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/26\">",
"      Kimura T, Suzuki K. Components of the electron transport system in adrenal steroid hydroxylase. Isolation and properties of non-heme iron protein (adrenodoxin). J Biol Chem 1967; 242:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/27\">",
"      Kominami S, Hara H, Ogishima T, Takemori S. Interaction between cytochrome P-450 (P-450C21) and NADPH-cytochrome P-450 reductase from adrenocortical microsomes in a reconstituted system. J Biol Chem 1984; 259:2991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/28\">",
"      Penning TM. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev 1997; 18:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/29\">",
"      Yanase T, Simpson ER, Waterman MR. 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 1991; 12:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/30\">",
"      Kominami S, Ochi H, Kobayashi Y, Takemori S. Studies on the steroid hydroxylation system in adrenal cortex microsomes. Purification and characterization of cytochrome P-450 specific for steroid C-21 hydroxylation. J Biol Chem 1980; 255:3386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/31\">",
"      White PC, Chaplin DD, Weis JH, et al. Two steroid 21-hydroxylase genes are located in the murine S region. Nature 1984; 312:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/32\">",
"      White PC, New MI, Dupont B. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A 1984; 81:7505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/33\">",
"      Chu JW, Kimura T. Studies on adrenal steroid hydroxylases. Molecular and catalytic properties of adrenodoxin reductase (a flavoprotein). J Biol Chem 1973; 248:2089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/34\">",
"      Chua SC, Szabo P, Vitek A, et al. Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A 1987; 84:7193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/35\">",
"      John ME, John MC, Simpson ER, Waterman MR. Regulation of cytochrome P-45011 beta gene expression by adrenocorticotropin. J Biol Chem 1985; 260:5760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/36\">",
"      Wang XL, Bassett M, Zhang Y, et al. Transcriptional regulation of human 11beta-hydroxylase (hCYP11B1). Endocrinology 2000; 141:3587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/37\">",
"      White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta-hydroxylase isozymes. Endocr Rev 1994; 15:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/38\">",
"      White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med 1994; 331:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/39\">",
"      Taymans SE, Pack S, Pak E, et al. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J Clin Endocrinol Metab 1998; 83:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/40\">",
"      Endoh A, Kristiansen SB, Casson PR, et al. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 1996; 81:3558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/41\">",
"      Ib&aacute;&ntilde;ez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev 2000; 21:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/42\">",
"      Wolkersd&ouml;rfer GW, Lohmann T, Marx C, et al. Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: a novel mechanism of immune-endocrine interaction. J Clin Endocrinol Metab 1999; 84:4220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/43\">",
"      Marx C, Bornstein SR, Wolkersd&ouml;rfer GW, et al. Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex. J Clin Endocrinol Metab 1997; 82:3136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/44\">",
"      Simpson ER, Waterman MR. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 1988; 50:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/45\">",
"      Clark BJ, Ranganathan V, Combs R. Steroidogenic acute regulatory protein expression is dependent upon post-translational effects of cAMP-dependent protein kinase A. Mol Cell Endocrinol 2001; 173:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/46\">",
"      Kramer RE, Simpson ER, Waterman MR. Induction of 11 beta-hydroxylase by corticotropin in primary cultures of bovine adrenocortical cells. J Biol Chem 1983; 258:3000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/47\">",
"      Kramer RE, Anderson CM, Peterson JA, et al. Adrenodoxin biosynthesis by bovine adrenal cells in monolayer culture. Induction by adrenocorticotropin. J Biol Chem 1982; 257:14921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/48\">",
"      Plump AS, Erickson SK, Weng W, et al. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J Clin Invest 1996; 97:2660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28391/abstract/49\">",
"      Trzeciak WH, Simpson ER, Scallen TJ, et al. Studies on the synthesis of sterol carrier protein-2 in rat adrenocortical cells in monolayer culture. Regulation by ACTH and dibutyryl cyclic 3',5'-AMP. J Biol Chem 1987; 262:3713.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 120 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-C801F8800B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28391=[""].join("\n");
var outline_f27_46_28391=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H239059600\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISM OF ACTH ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CHOLESTEROL SUBSTRATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CORTISOL BIOSYNTHESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pregnenolone synthesis by CYP11A1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Conversion of pregnenolone to progesterone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Progesterone to 17-alpha-hydroxyprogesterone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      17-alpha-hydroxyprogesterone to 11-deoxycortisol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Conversion of 11-deoxycortisol to cortisol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ALDOSTERONE BIOSYNTHESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ADRENAL ANDROGEN BIOSYNTHESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ACUTE AND CHRONIC ACTIONS OF ACTH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H239059580\">",
"      METABOLISM OF ADRENAL STEROIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OVERVIEW OF CAH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H239059600\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/120\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/120|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/7/123\" title=\"figure 1\">",
"      Adrenal steroid synthesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/120|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/20/19787\" title=\"table 1\">",
"      Steroidogenic enzymes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/0/39949\" title=\"table 2\">",
"      Different forms of CAH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=related_link\">",
"      Adrenal hyperandrogenism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2376?source=related_link\">",
"      Chapter 6C: Aldosterone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=related_link\">",
"      Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/9/24726?source=related_link\">",
"      Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=related_link\">",
"      Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22615?source=related_link\">",
"      Familial hyperaldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11034?source=related_link\">",
"      Genetics and clinical presentation of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/1/9240?source=related_link\">",
"      Metabolism of adrenal steroids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35641?source=related_link\">",
"      Uncommon causes of congenital adrenal hyperplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_46_28392="Butalbital compound and codeine: Drug information";
var content_f27_46_28392=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Butalbital compound and codeine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?10/26/10661?source=see_link\">",
"    see \"Butalbital compound and codeine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F14854553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Warns of Codeine Use in Children After Tonsillectomy and/or Adenoidectomy",
"     </span>",
"     <span class=\"collapsible-date\">",
"      August 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The FDA has issued a Drug Safety Communication after reviewing reports of children who developed serious adverse effects, including death, after receiving codeine in the usual dosage range for pain relief following tonsillectomy and/or adenoidectomy for obstructive sleep apnea syndrome. Three deaths occurred in children that had evidence of a genetic variation (&ldquo;ultrarapid metabolizers&rdquo;) which results in faster and more complete conversion of codeine to morphine, possibly leading to overdose or death. The estimated incidence of this genetic variation is ~1-7 per 100 people, but may be higher in some ethnic groups.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Healthcare professionals should be aware of the risks associated with the administration of codeine or codeine-containing drugs in children after tonsillectomy and/or adenoidectomy for obstructive sleep apnea and should use the lowest effective dose for the least amount of time on an as-needed basis. Parents and caregivers who observe signs of overdose in a child such as unusual sleepiness, confusion, or difficult or noisy breathing should stop codeine administration and seek medical attention immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further information may be found at",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#",
"       </a>",
"       .",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F143529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ascomp&reg; with Codeine;",
"     </li>",
"     <li>",
"      Fiorinal&reg; with Codeine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F143530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Fiorinal&reg;-C 1/2;",
"     </li>",
"     <li>",
"      Fiorinal&reg;-C 1/4;",
"     </li>",
"     <li>",
"      Tecnal C 1/2;",
"     </li>",
"     <li>",
"      Tecnal C 1/4",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F143546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic Combination (Opioid);",
"     </li>",
"     <li>",
"      Barbiturate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F143533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tension headache: Oral: 1-2 capsules every 4 hours as needed (maximum: 6 capsules/day)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F143534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; however, barbiturates (butalbital) are generally not recommended in the elderly.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustments recommended. Use with caution due to increased risk of adverse effects.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustments provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F143519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule: Butalbital 50 mg, aspirin 325 mg, caffeine 40 mg, and codeine phosphate 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ascomp&reg; with Codeine, Fiorinal&reg; with Codeine: Butalbital 50 mg, aspirin 325 mg, caffeine 40 mg, and codeine phosphate 30 mg [may contain benzyl alcohol]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F143505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F143548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-III",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F143520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of symptoms of complex tension (muscle contraction) headache",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F143551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Fiorinal&reg; may be confused with Fioricet&reg;, Florical&reg;, Florinef&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F143544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness/lightheadedness (3%), drowsiness (2%), intoxicated feeling (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain/nausea (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Agitation, allergic reaction, anaphylactic shock, anorexia, chest pain, cholangiocarcinoma, depression, disorientation, diuresis, dysphagia, dysuria, edema, epistaxis, erythema multiforme, esophagitis, exfoliative dermatitis, fainting, gastroenteritis, GI spasm, hallucinations, hives, hypotension, nervousness, neuropathy, numbness, palpitations, psychosis, pyloric ulcer, rash, renal impairment, slurred speech, syncope, tachycardia, tinnitus, toxic epidermal necrolysis, unconsciousness, vertigo, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Potential reactions associated with components of Fiorinal&reg; with Codeine include acute airway obstruction, anemia, bleeding time prolonged, cardiac stimulation, dependence, hemolytic anemia, hepatitis, hyperglycemia, irritability, nephrotoxicity, occult blood loss, peptic ulcer, pruritus, renal toxicity (high doses, prolonged therapy) thrombocytopenia, tremor, urate excretion impaired",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F143522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to butalbital, codeine, aspirin, caffeine, or any component of the formulation; opium derivatives; hemorrhagic diathesis (eg, hemophilia, hypoprothrombinemia, von Willebrand disease, the thrombocytopenias, thrombasthenia, and other ill-defined hereditary platelet dysfunctions, severe vitamin K deficiency, and severe liver damage); nasal polyp syndrome, angioedema, and bronchospastic reactivity to aspirin or other NSAIDs; peptic ulcer or other serious GI lesions; porphyria",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F143508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenanthrene hypersensitivity: Use with caution in patients with hypersensitivity reactions to other phenanthrene-derivative opioid agonists (hydrocodone, hydromorphone, levorphanol, oxycodone, oxymorphone).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Salicylate sensitivity: Patients with sensitivity to tartrazine dyes, nasal polyps, and asthma may have an increased risk of salicylate sensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding disorders: Use with caution in patients with platelet and bleeding disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal disease: Use with caution in patients with erosive gastritis or peptic ulcer disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticoagulant therapy: Use with caution in patients on anticoagulant therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CYP2D6 &ldquo;ultrarapid metabolizers&rdquo;: Use caution in patients with two or more copies of the variant CYP2D6*2 allele; may have extensive conversion from codeine to morphine and thus increased opioid-mediated effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; there is a greater potential for critical respiratory depression, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects. Decrease initial dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children and teenagers who have or are recovering from chickenpox or flu-like symptoms should not use this product. Changes in behavior (along with nausea and vomiting) may be an early sign of Reye's syndrome; patients should be instructed to contact their healthcare provider if these occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Caffeine: May cause CNS and cardiovascular stimulation, as well as GI irritation in high doses. Use with caution in patients with a history of peptic ulcer or GERD; avoid in patients with symptomatic cardiac arrhythmias.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F143541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F143513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Salicylates may diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF.  The effects are likely dose-related.  100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetaminophen: Barbiturates may increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adenosine: Caffeine may diminish the therapeutic effect of Adenosine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alendronate: Aspirin may enhance the adverse/toxic effect of Alendronate. Specifically gastrointestinal adverse events.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Salicylates may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Tricyclic, Tertiary Amine): May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Barbiturates may decrease the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Atenolol; Levobunolol; Metipranolol; Nadolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Barbiturates may increase the metabolism of Calcium Channel Blockers.  Management: Monitor for decreased therapeutic effects of calcium channel blockers with concomitant barbiturate therapy. Calcium channel blocker dose adjustments may be necessary. Nimodipine Canadian labeling contraindicates concomitant use with phenobarbital.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May enhance the anticoagulant effect of Salicylates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carbonic Anhydrase Inhibitors: Salicylates may enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Brinzolamide; Dorzolamide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloramphenicol: Barbiturates may increase the metabolism of Chloramphenicol. Chloramphenicol may decrease the metabolism of Barbiturates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): Barbiturates may diminish the therapeutic effect of Contraceptives (Estrogens). Contraceptive failure is possible.  Management: Use of a non-hormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): Barbiturates may diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible.  Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Salicylates may enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Barbiturates may decrease the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Barbiturates may increase the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.  Management: Increase monitoring for signs/symptoms of bleeding. The Canadian product monograph for dabigatran specifically recommends avoiding concomitant use with GIIb/IIIa inhibitors or ticlopidine, or with aspirin used for stroke prevention in atrial fibrillation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Barbiturates may increase the metabolism of Disopyramide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: Salicylates may increase the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Doxycycline: Barbiturates may decrease the serum concentration of Doxycycline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Salicylates may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: Weigh potential benefits of drotrecogin against increased bleeding risk in patients who have received  platelet inhibitors including aspirin (over 650 mg daily within 1 week). Monitor for bleeding and stop infusion if clinically important bleeding occurs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide: Barbiturates may decrease the serum concentration of Etoposide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide Phosphate: Barbiturates may decrease the serum concentration of Etoposide Phosphate. Barbiturates may increase the metabolism, via CYP isoenzymes, of etoposide phosphate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Felbamate: Barbiturates may decrease the serum concentration of Felbamate. Felbamate may increase the serum concentration of Barbiturates.  Management: Monitor for elevated barbiturate concentrations/toxicity if felbamate is initiated/dose increased, or reduced concentrations/effects if felbamate is discontinued/dose decreased. Refer to phenobarbital dosing guidelines for patients receiving that agent.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Floctafenine may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Formoterol: Caffeine may enhance the adverse/toxic effect of Formoterol. Caffeine may enhance the hypokalemic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Barbiturates may enhance the CNS depressant effect of Fosphenytoin. Barbiturates may decrease the serum concentration of Fosphenytoin. Fosphenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ginkgo Biloba: May enhance the anticoagulant effect of Salicylates. Management: Consider alternatives to this combination of agents. Monitor for signs and symptoms of bleeding (especially intracranial bleeding) if salicylates are used in combination with ginkgo biloba.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucosamine: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Griseofulvin: Barbiturates may decrease the serum concentration of Griseofulvin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin: Aspirin may enhance the anticoagulant effect of Heparin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Salicylates may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving salicylates (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of Barbiturates. Management: Consider a decrease in the barbiturate dose, as appropriate, when used together with hydroxyzine.  With concurrent use, monitor patients closely for excessive response to the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: Salicylates may enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indacaterol: Caffeine may enhance the adverse/toxic effect of Indacaterol. Caffeine may enhance the hypokalemic effect of Indacaterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Influenza Virus Vaccine (Live/Attenuated): May enhance the adverse/toxic effect of Salicylates. Specifically, Reye's syndrome may develop.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Ketorolac (Nasal) may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Ketorolac (Systemic) may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: Barbiturates may decrease the serum concentration of LamoTRIgine.  Management: See lamotrigine prescribing information for specific age-dependent dosing guidelines regarding concurrent use with a barbiturate, as well as for adjusting lamotrigine dosing if concurrent barbiturate therapy is discontinued.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Salicylates may diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Meperidine: Barbiturates may enhance the CNS depressant effect of Meperidine. Barbiturates may increase serum concentrations of the active metabolite(s) of Meperidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Barbiturates may enhance the CNS depressant effect of Methadone. Barbiturates may decrease the serum concentration of Methadone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Salicylates may increase the serum concentration of Methotrexate. Salicylate doses used for prophylaxis of cardiovascular events are not likely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the antiplatelet effect of Aspirin. Aspirin may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, aspirin may decrease absorption of ascorbic acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Aspirin may enhance the adverse/toxic effect of NSAID (COX-2 Inhibitor).  Management: Concurrent use of aspirin at doses beyond cardioprotective levels is not recommended.  While concurrent use of low-dose aspirin with a COX-2 inhibitor is permissable, patients should be monitored closely for signs/symptoms of GI ulceration/bleeding.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): May enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Aspirin may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of aspirin with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Specifically, the risk of bleeding may be increased by concurrent use of these agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May enhance the CNS depressant effect of Barbiturates. Barbiturates may decrease the serum concentration of Phenytoin. Phenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Acid Phosphate: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PRALAtrexate: Salicylates may increase the serum concentration of PRALAtrexate. Salicylate doses used for prophylaxis of cardiovascular events are unlikely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: May enhance the adverse/toxic effect of Barbiturates. Primidone is converted to phenobarbital, and thus becomes additive with existing barbiturate therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: Salicylates may diminish the therapeutic effect of Probenecid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: Barbiturates may decrease the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pyridoxine: May increase the metabolism of Barbiturates. Apparent in high pyridoxine doses (eg, 200 mg/day)",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Barbiturates may enhance the hepatotoxic effect of QuiNIDine. Barbiturates may decrease the serum concentration of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: May decrease the metabolism of Caffeine.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Gemifloxacin; Levofloxacin (Systemic); Lomefloxacin; Moxifloxacin (Systemic); Nalidixic Acid; Ofloxacin (Systemic); Sparfloxacin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Regadenoson: Caffeine may diminish the vasodilatory effect of Regadenoson.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.  Management: Avoid concurrent use of clopidogrel with rivaroxaban unless the anticipated benefits outweigh the risks of bleeding.  Avoid concurrent use of rivaroxaban with other antiplatelet agents whenever possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of other Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatostatin Analogs: May decrease the metabolism of Codeine. The formation of two major codeine metabolites (morphine and norcodeine) may be impaired by somatostatin analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Teniposide: Barbiturates may decrease the serum concentration of Teniposide.  Management: Consider alternatives to combined treatment with barbiturates and teniposide due to the potential for decreased teniposide concentrations.  If the combination cannot be avoided, monitor teniposide response closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Teriflunomide: May decrease the serum concentration of Caffeine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Barbiturates may decrease the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Barbiturates may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Salicylates may enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ticagrelor: Aspirin may enhance the antiplatelet effect of Ticagrelor. Aspirin may diminish the therapeutic effect of Ticagrelor. More specifically, the benefits of ticagrelor relative to clopidogrel may be diminished in patients receiving daily aspirin doses greater than 100-150 mg daily.  Management: Avoid daily aspirin doses greater than 100 mg in patients receiving ticagrelor.  Canadian recommendations are to avoid daily aspirin doses greater than 150 mg.  Daily low-dose aspirin (U.S.: 75-100 mg; Canada: 75-150 mg) is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiludronate: Aspirin may decrease the serum concentration of Tiludronate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Barbiturates may increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: Salicylates may increase the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varicella Virus-Containing Vaccines: Salicylates may enhance the adverse/toxic effect of Varicella Virus-Containing Vaccines. Reye's Syndrome may develop.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Salicylates may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Barbiturates may increase the metabolism of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: Barbiturates may decrease the serum concentration of Voriconazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F143527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F143514\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6107083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted with this combination. Lissencephaly, pachygyria, and heterotopic gray matter were noted in a premature infant whose mother took this combination throughout pregnancy; mild developmental delay and seizures were also observed at 1 year of age. Withdrawal seizures were reported in an infant 2 days after birth following maternal use of a butalbital product during the last 2 months of pregnancy; butalbital was detected in the newborns serum. Also refer to the individual monographs for aspirin, caffeine, and codeine for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F143536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F6107085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Barbiturates, aspirin, caffeine, and codeine are excreted in breast milk. Also refer to the individual monographs for aspirin, caffeine, and codeine for additional information",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Ascomp-Codeine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-325-40-30 mg (100): $139.95",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Butalbital-ASA-Caff-Codeine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-325-40-30 mg (100): $138.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Fiorinal/Codeine #3 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-325-40-30 mg (100): $547.94",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6107091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serial hepatic and renal function tests (in patients with impairment)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F143524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Fiorinal-C 1/2 (CA);",
"     </li>",
"     <li>",
"      Fiorinal-C 1/4 (CA);",
"     </li>",
"     <li>",
"      Tecnal C 1/2 (CA);",
"     </li>",
"     <li>",
"      Tecnal C 1/4 (CA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F6107087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Butalbital is a short-to-intermediate acting barbiturate; aspirin inhibits prostaglandin synthesis and has analgesic, antipyretic and anti-inflammatory actions; caffeine is a CNS stimulant; codeine is a narcotic analgesic and antitussive which produced generalized CNS depression. The combination product is for the treatment of tension headache; however, the role of each component in the relief of symptoms is not completely understood.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F6107089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents. Bioavailability of the combination is identical to their bioavailability when codeine is administered separately from butalbital, aspirin, and caffeine.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Capone ML, Sciulli MG, Tacconelli S, et al,  &ldquo;Pharmacodynamic Interaction of Naproxen With Low-Dose Aspirin in Healthy Subjects,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2005, 45(8):1295-1301.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/46/28392/abstract-text/15837265/pubmed\" id=\"15837265\" target=\"_blank\">",
"        15837265",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Catella-Lawson F, Reilly MP, Kapoor SC, et al, &ldquo;Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 345(25):1809-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/46/28392/abstract-text/11752357/pubmed\" id=\"11752357\" target=\"_blank\">",
"        11752357",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cryer B, Verlin RG, Cooper SA, et al, &ldquo;Double-Blind, Randomized, Parallel, Placebo-Controlled Study of Ibuprofen Effects on Thromboxane B2 Concentrations in Aspirin-Treated Healthy Adult Volunteers,&rdquo;",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 2005, 27(2):185-191.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/46/28392/abstract-text/15811481/pubmed\" id=\"15811481\" target=\"_blank\">",
"        15811481",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/46/28392/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8824 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-6BDFF69EB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28392=[""].join("\n");
var outline_f27_46_28392=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14854553\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143529\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143530\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143546\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143533\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143534\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682370\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682371\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143519\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143505\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143548\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143520\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143551\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143544\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143522\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143508\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143541\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143513\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143527\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143514\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107083\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143536\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107085\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422203\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107091\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143524\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107087\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107089\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8824\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8824|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?10/26/10661?source=related_link\">",
"      Butalbital compound and codeine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_46_28393="SLE Mesangial";
var content_f27_46_28393=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F80250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F80250&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing mesangial proliferative glomerulonephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a mesangial glomerulonephritis showing segmental areas of increased mesangial matrix and cellularity (arrows). This finding alone can be seen in many diseases, including lupus nephritis and IgA nephropathy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28393=[""].join("\n");
var outline_f27_46_28393=null;
var title_f27_46_28394="Overview of the benefits and risks of exercise";
var content_f27_46_28394=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the benefits and risks of exercise",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/46/28394/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/46/28394/contributors\">",
"     Douglas M Peterson, MD, MBA, FACP, FACSM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/46/28394/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/46/28394/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/46/28394/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/46/28394/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/46/28394/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical inactivity is a major health problem worldwide, particularly in developed countries. The medical literature clearly demonstrates beneficial effects of physical activity on several health outcomes, including cardiovascular disease and all-cause mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/1\">",
"     1",
"    </a>",
"    ]. Although there are risks associated with exercise in some patients, the benefits outweigh the risks in most patients.",
"   </p>",
"   <p>",
"    Counseling patients on exercise may be challenging, as many patients have different perceived barriers to exercising. Thus, an individualized approach to the exercise prescription may be needed to effect behavioral change.",
"   </p>",
"   <p>",
"    This topic will provide an overview of the benefits and risks of exercise in adults, including an evidence-based exercise prescription. Exercise recommendations for children and adolescents, as well as for specific conditions, are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14298?source=see_link\">",
"     \"Overview of physical activity and strength training in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21144?source=see_link\">",
"     \"Role of physical activity and exercise in obese adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/59/2998?source=see_link\">",
"     \"Exercise in the treatment and prevention of hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20265?source=see_link\">",
"     \"Effects of exercise in diabetes mellitus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7657?source=see_link\">",
"     \"Recommendations for exercise during pregnancy and the postpartum period\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical activity and exercise are not interchangeable terms [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical activity is defined as bodily movement produced by the contraction of skeletal muscle that increases energy expenditure above the basal level. Categories of physical activity include occupational, household, leisure time, and transportation.",
"     </li>",
"     <li>",
"      The term \"exercise\" is a form of physical activity that is planned, structured, repetitive, and purposeful with a main objective of improvement or maintenance of one or more components of physical fitness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Physical activity may be measured in terms of METs (metabolic equivalents), units used to estimate the metabolic cost (oxygen consumption) of physical activity. One MET equals the resting metabolic rate of approximately 3.5 mL",
"    <span class=\"nowrap\">",
"     O2/kg/min,",
"    </span>",
"    and represents the approximate rate of oxygen consumption of a seated adult at rest. Moderate physical activity includes activity performed at an intensity of 3 to 6 METs, or the equivalent of walking briskly at approximately 5 to 8 kilometers (3 to 5 miles) per hour. Leisure cycling, moderate effort swimming, playing golf (walking), general cleaning at home, or lawn mowing also constitute moderate physical activity (",
"    <a class=\"graphic graphic_figure graphicRef73838 \" href=\"UTD.htm?25/14/25824\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/3\">",
"     3",
"    </a>",
"    ]. Vigorous physical activity includes activity performed at &gt;6 METs, such as running, rope jumping, and calisthenics (eg, push-ups, pull-ups, sit-ups, jumping jacks).",
"   </p>",
"   <p>",
"    Physical fitness can be described as the ability to carry out daily tasks with vigor and alertness, without undue fatigue, and with ample energy to enjoy leisure time pursuits and meet unforeseen emergencies [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2\">",
"     2",
"    </a>",
"    ]. The scope of physical fitness includes cardiorespiratory endurance, skeletal muscular endurance, skeletal muscular strength, skeletal muscular power, speed, flexibility, agility, balance, reaction time, and body composition [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/4\">",
"     4",
"    </a>",
"    ]. Cardiorespiratory endurance is defined as a health related component of physical fitness that relates to the ability of the circulatory and respiratory systems to supply oxygen during sustained physical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHYSICAL INACTIVITY AS A GLOBAL HEALTH PROBLEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large prospective cohort studies from several countries around the world have found that sedentary behavior is widely prevalent and is associated with a variety of poor health outcomes, including increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/5\">",
"     5",
"    </a>",
"    ]. One study calculated the attributable risk for premature mortality and estimated that physical activity worldwide causes 9 percent of premature mortality, accounting for 5.3 million deaths worldwide in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/6\">",
"     6",
"    </a>",
"    ]. A 10 percent reduction in inactivity could avert 533,000 deaths every year.",
"   </p>",
"   <p>",
"    Worldwide, one out of every five adults is physically inactive [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/7\">",
"     7",
"    </a>",
"    ]. Physical inactivity is particularly prevalent in more developed countries and among women, older persons, and those with lower incomes. In addition to lack of regular exercise, the percentage of time spent in sedentary behaviors (watching television or in front of a computer) is increasing [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a United States, many Americans do not meet national guidelines for being physically active. In a sample of children and adults from the National Health and Nutrition Examination Survey (NHANES) 2003-2004, activity monitoring found that 55 percent of waking hours were spent in sedentary behaviors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/10\">",
"     10",
"    </a>",
"    ]. Subsequent NHANES data in 2005-2006 indicate that the percentage of sedentary time is increasing (58 percent), while time spent in light activity is decreasing [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/11\">",
"     11",
"    </a>",
"    ]. According to the National Health Interview Survey 2008, 56.5 percent of respondents were not aerobically active, based on the 2008 Physical Activity Guidelines for Americans: 150 minutes of moderate intensity activity or 75 minutes of vigorous intensity activity weekly [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. In telephone survey data from the 2007 Behavioral Risk Factor Surveillance System, 64.3 percent of adults met minimum physical activity guidelines through nonoccupational activity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/13\">",
"     13",
"    </a>",
"    ]. When occupational activity was included (mostly walking or heavy labor during work), an additional 6.5 percent of adults likely met the guidelines. However, this study was limited by a low response rate and interviews being conducted by telephone only.",
"   </p>",
"   <p>",
"    Prolonged sedentary time is associated with increased risk for diabetes, cardiovascular disease, and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/14\">",
"     14",
"    </a>",
"    ], and may be offset by time spent in light activity (eg, standing and walking), as well as by more vigorous exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/8\">",
"     8",
"    </a>",
"    ]. Regular physical activity and higher cardiorespiratory fitness decrease overall mortality in a dose-response fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/1,15\">",
"     1,15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Mortality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Despite the widespread prevalence of physical inactivity, its associated health risks, and the potential of increasing physical activity to improve health outcomes, clinicians do not routinely screen patients for physical inactivity or provide adequate counseling. In developed countries, only 13 to 34 percent of primary care patients reported receiving advice on physical activity from their primary care physician [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. The efficacy of exercise counseling is discussed below. (See",
"    <a class=\"local\" href=\"#H36\">",
"     'Efficacy of exercise counseling'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EXERCISE PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term adaptations to exercise training include effects upon the musculoskeletal, metabolic, cardiovascular, and respiratory systems. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=see_link\">",
"     \"Exercise physiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     BENEFITS OF EXERCISE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise favorably impacts multiple systems and health outcomes (",
"    <a class=\"graphic graphic_table graphicRef51565 \" href=\"UTD.htm?10/2/10283\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef59285 \" href=\"UTD.htm?19/51/20284\">",
"     table 2",
"    </a>",
"    ). A graded relationship between exercise and the development of common chronic conditions (including cardiovascular disease, diabetes mellitus, chronic lung disease, chronic kidney disease, Alzheimer disease, and some cancers) has been observed, such that greater exercise in midlife was associated with compression of morbidity in later years with a decreased risk of multiple chronic conditions in the last five years of life [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most data on the benefits of exercise come from observational trials. There are no high-quality, long-term, randomized trials of exercise for prevention of cardiovascular disease or death in a healthy population. Large observational studies suggest that regular exercise reduces risk of all-cause mortality for most individuals, including men and women, as well as younger and older populations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/1,20-27\">",
"     1,20-27",
"    </a>",
"    ]. The beneficial effects appear to be dose-dependent. Representative studies include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of 33 observational studies (102,980 participants) reported the risk for all-cause mortality related to cardiorespiratory fitness (CRF) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/1\">",
"       1",
"      </a>",
"      ]. CRF, based on maximal aerobic capacity, was ranked as high (&ge;10.9 METs), intermediate (7.9 to 10.8 METs), or low (&lt;7.9 METs). Participants with low CRF had an increased risk of all-cause mortality compared to those with high CRF (RR 1.7, 95% CI 1.5-1.9) and intermediate CRF (RR 1.4, 95% CI 1.3-1.5). These data indicate that measured aerobic fitness, not just reported exercise, was inversely associated with mortality risk.",
"     </li>",
"     <li>",
"      In a retrospective cohort study, physical activity habits were analyzed in 10,269 Harvard College alumni over 12 years [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/21\">",
"       21",
"      </a>",
"      ]. Those men who engaged in moderately vigorous sports activity had a 23 percent lower risk of death than those who were less active. The improvement in survival with exercise was equivalent and additive to other lifestyle measures such as smoking cessation, control of hypertension, and avoidance of obesity (",
"      <a class=\"graphic graphic_figure graphicRef56864 \" href=\"UTD.htm?4/18/4398\">",
"       figure 2",
"      </a>",
"      ). This highlights the importance of exercise given that the specific benefits of regular exercise persist despite individuals attempting to improve multiple lifestyle habits concurrently.",
"     </li>",
"     <li>",
"      Moderate levels of physical activity appear to confer a significant health benefit, although greater amounts of activity afford greater protection from premature death (",
"      <a class=\"graphic graphic_figure graphicRef74679 \" href=\"UTD.htm?20/49/21277\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/24\">",
"       24",
"      </a>",
"      ]. Progressing from lower to higher levels of physical activity has been shown to reduce overall mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/21,23,25,27\">",
"       21,23,25,27",
"      </a>",
"      ]. Vigorous exercise (at least 20 minutes three times a week) combined with regular exercise (at least 30 minutes of moderate activity most days of the week) was associated with a 50 percent decreased mortality risk in an observational study involving over 250,000 men and women aged 50 to 71 years [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/23\">",
"       23",
"      </a>",
"      ]. Data from the Framingham Heart Study show that moderate and high, compared to low, physical activity levels increase life expectancy for men at age 50 by 1.3 and 3.7 years, respectively; results were similar for women (1.5 and 3.5 years) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Total daily activity energy expenditure may correlate more strongly with mortality benefit than self-reported exercise intensity. Comparing mortality among individuals in the highest versus lowest tertile for activity energy expenditure in a study of 302 high functioning volunteers (age 70 to 82 years), the hazard ratio (HR) for mortality over six years was 0.31 (95% CI 0.14-0.69); self-reported exercise intensity did not differ significantly across the energy tertiles, although frequency of paid employment and stair climbing was greater in the higher energy groups [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have shown a strong inverse relationship between habitual exercise and the risk of coronary disease, cardiac events, and cardiovascular death for both primary and secondary prevention (",
"    <a class=\"graphic graphic_figure graphicRef81608 \" href=\"UTD.htm?28/55/29565\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/1,28-30\">",
"     1,28-30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Observational studies suggest that exercise may also have the following beneficial effects:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aerobic training induces beneficial effects on lipoproteins (eg, decrease in very low density lipoprotein, increase in high density lipoprotein), body composition, and aerobic capacity, as well as improves hemostatic factors associated with thrombosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17015?source=see_link\">",
"       \"Effects of exercise on lipoproteins and hemostatic factors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Regular physical activity is associated with decreased levels of markers of inflammation (CRP and IL6) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/31\">",
"       31",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=see_link\">",
"       \"C-reactive protein in cardiovascular disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link&amp;anchor=H24#H24\">",
"       \"Overview of the risk equivalents and established risk factors for cardiovascular disease\", section on 'Inflammatory markers'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Long-term aerobic exercise and resistance (strength) training have a beneficial effect upon the systemic blood pressure [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/59/2998?source=see_link\">",
"       \"Exercise in the treatment and prevention of hypertension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Exercise may reduce the risk of stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/33\">",
"       33",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"       \"Exercise and fitness in the prevention of cardiovascular disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=see_link\">",
"       \"Secondary prevention of stroke: Risk factor reduction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aerobic exercise may improve glycemic control, insulin sensitivity, and may prevent the development of type 2 diabetes in high-risk groups. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20265?source=see_link\">",
"     \"Effects of exercise in diabetes mellitus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link&amp;anchor=H11#H11\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Cancer prevention and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise may provide modest protection against breast, intestinal, prostate, endometrial, and pancreatic cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Substantial observational data suggest that regular physical activity, either occupational or leisure time, appears to be associated with protection from both proximal and distal colorectal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. In a meta-analysis of 21 studies, there was a significant 27 percent reduced risk of proximal colon cancer when comparing the most versus the least active individuals (relative risk [RR] 0.73, 95% CI 0.66-0.81) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/37\">",
"     37",
"    </a>",
"    ]. An almost identical result was found for distal colon cancer (RR 0.74, 95% CI 0.68-0.80).",
"   </p>",
"   <p>",
"    For patients treated for cancer, observational studies have reported a link between survival and exercise, with most of the data coming from survivors with breast, colorectal, or prostate cancers. In addition, interventional studies have shown a direct effect of exercise on other outcomes, including fatigue and quality of life. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43321?source=see_link\">",
"     \"The roles of diet, physical activity, and body weight in cancer survivorship\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27098?source=see_link&amp;anchor=H7#H7\">",
"     \"Cancer-related fatigue: Treatment\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preventing or treating obesity may lead to significant health benefits over the course of a lifetime. Compared to a weight loss diet alone, diet coupled with either exercise or exercise and resistance training is associated with a greater reduction in body fat and enhanced preservation of body lean mass, compared to weight loss diet alone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21144?source=see_link\">",
"     \"Role of physical activity and exercise in obese adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Aerobic exercise and resistance training, even in the absence of caloric restriction, may result in weight loss and a reduction in body fat [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/32,38,39\">",
"     32,38,39",
"    </a>",
"    ]. Long-term (20 year) follow-up of participants in the Coronary Artery Risk Development in Young Adults (CARDIA) study found that habitual activity was associated with less weight gain at middle age, especially in women [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/40\">",
"     40",
"    </a>",
"    ]. However, a 15 year longitudinal study in postmenopausal women found that a minimum of 60 minutes a day of moderate intensity activity, sustained over years, was necessary to prevent weight gain, and was effective only in women whose initial BMI was &lt;25",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    (normal or underweight) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H496083\">",
"    <span class=\"h2\">",
"     Osteoporosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight-bearing exercise is associated with an increase in bone mineral density in men and women. In addition, among patients with osteoporosis, exercise is associated with a decreased risk of hip fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/21/33113?source=see_link&amp;anchor=H15#H15\">",
"     \"Prevention of osteoporosis\", section on 'Physical activity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Smoking cessation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vigorous exercise modestly facilitates short- and long-term smoking cessation in women when combined with a cognitive-behavioral smoking cessation program [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/42\">",
"     42",
"    </a>",
"    ]. Vigorous exercise also delays weight gain following smoking cessation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Gallstones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical activity is associated with a decreased risk of symptomatic cholelithiasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=see_link&amp;anchor=H16#H16\">",
"     \"Epidemiology of and risk factors for gallstones\", section on 'Decreased physical activity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Function and cognition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies suggest that physical activity may reduce the risk of dementia and cognitive decline in older patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36202?source=see_link&amp;anchor=H14#H14\">",
"     \"Risk factors for dementia\", section on 'Lifestyle and activity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41369?source=see_link&amp;anchor=H10#H10\">",
"     \"Prevention of dementia\", section on 'Lifestyle and activity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Psychological",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regular exercise reduces stress, anxiety, and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/43\">",
"     43",
"    </a>",
"    ]. In one randomized trial, higher exercise energy expenditure led to greater improvement in measures of both physical and psychological quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exercise is recommended in the treatment of depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H48#H48\">",
"     \"Initial treatment of depression in adults\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     RISKS OF EXERCISE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of physical activity far outweigh the possible associated risks in the majority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2\">",
"     2",
"    </a>",
"    ]. Musculoskeletal injury is the most common risk of exercise. More serious but much less common risks include arrhythmia, sudden cardiac arrest, and myocardial infarction.",
"   </p>",
"   <p>",
"    One study analyzed available data from several exercise trials in diverse patient populations (mostly sedentary at baseline and some with identified cardiovascular risk factors) and found that exercise was associated with an adverse change in one or more metabolic risk factors for cardiovascular disease in 8 to 13 percent of participants, while a similar proportion of participants experienced an unusually strong positive change in these risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/45\">",
"     45",
"    </a>",
"    ]. Based upon measurements in a small sample of controls, the authors felt that these changes were larger than would be expected just with random variation; however, random variation still appears to be a likely explanation for the results. The study did not look at actual cardiovascular event rates.",
"   </p>",
"   <p>",
"    Any potential risks of routine exercise do not outweigh its benefits, in the absence of a contraindication to exercise. (See",
"    <a class=\"local\" href=\"#H263834579\">",
"     'Contraindications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H677150\">",
"    <span class=\"h2\">",
"     Musculoskeletal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute strains and tears, inflammation of various types, chronic strain, stress fractures, traumatic fractures, nerve palsies, tendonitis, and bursitis all may occur during or as result of physical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Musculoskeletal injuries vary based on a variety of factors, including age (child, adolescent, adult, older adult), type of activity (eg, contact sports, high impact exercises, walking), and intensity.",
"   </p>",
"   <p>",
"    Although studies indicate that those who engage in sports activities run a higher risk of incurring minor injury, people who do not participate in sports or other physical activity on a regular basis are more likely to incur more severe injuries when engaging in such activity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many of the musculoskeletal injuries are secondary to overuse [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Two of the most common risk factors for injury among runners, for example, are longer running distances and history of previous injury [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44775?source=see_link\">",
"     \"Musculoskeletal injury in the young athlete: Overview of treatment principles for nonoperative injuries\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=see_link\">",
"     \"Overview of running injuries of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Arrhythmia",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an increased risk of arrhythmia during exercise in patients with underlying heart disease or a prior history of arrhythmia. Exercise training may reduce atrial and ventricular arrhythmia risk by increasing myocardial oxygen supply and by reducing sympathetic nervous system activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23192?source=see_link\">",
"     \"Arrhythmia in athletes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=see_link\">",
"     \"Risk of sudden cardiac death in athletes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A separate issue, ventricular and atrial arrhythmias occurring during exercise testing, is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/36/36424?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical significance and treatment of ventricular premature beats\", section on 'Exercise-induced'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29129?source=see_link&amp;anchor=H7#H7\">",
"     \"Exercise ECG testing to determine prognosis of coronary heart disease\", section on 'Ventricular arrhythmias'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29129?source=see_link&amp;anchor=H8#H8\">",
"     \"Exercise ECG testing to determine prognosis of coronary heart disease\", section on 'Atrial arrhythmias'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Sudden cardiac death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sudden cardiac death (SCD) is rare, but may occur during physical or sexual activity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. The risk of SCD in athletes is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=see_link\">",
"     \"Risk of sudden cardiac death in athletes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The increase in risk is seen in both men and women. In the Physicians' Health Study of 21,481 males followed for 12 years, the absolute risk of SCD during any one episode of vigorous exercise was low (one death per 1.51 million episodes of exercise) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/53\">",
"     53",
"    </a>",
"    ]. In the Nurses' Health Study of 69,693 women, the absolute risk was even lower, with one death per 36.5 million hours of exertion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/54\">",
"     54",
"    </a>",
"    ]. The risk of cardiac arrest is less or may not be increased at all if there is habitual, heavy leisure-time physical activity, as noted in both the Physicians' Health Study and the Nurses' Health Study [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mechanisms of SCD in those who exercise include coronary artery disease, arrhythmias (especially ventricular tachycardia and ventricular fibrillation), structural heart disease, and myocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/55\">",
"     55",
"    </a>",
"    ]. Causes of SCD in people who exercise can be divided according to age [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/51\">",
"     51",
"    </a>",
"    ]. SCD is generally a result of atherosclerotic coronary artery disease in those over age 35 years. It is more likely to be due to congenital abnormalities such as hypertrophic cardiomyopathy, coronary anomalies, or to myocarditis in younger individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of sudden cardiac arrest and sudden cardiac death\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because the increase in risk of SCD during or just after activity is low, the long-term health benefits of exercise outweigh the risks in patient with and without established heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical or sexual activity is associated with a temporary increase in the risk of having a myocardial infarction (MI), particularly among those who exercise infrequently and have multiple cardiac risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/52,56,57\">",
"     52,56,57",
"    </a>",
"    ]. In a study of 1194 patients who completed a survey within two weeks of having an MI, physical exertion at the onset of infarction was reported in 7.1 percent of the case patients compared with 3.9 percent of matched controls prior to the onset of the control event [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/57\">",
"     57",
"    </a>",
"    ]. The adjusted relative risk of having engaged in strenuous physical activity at the onset of the MI was 2.1; the relative risk was much higher in patients who performed regular exercise less than four times per week and compared to those who exercised four or more times per week (relative risk 6.9 versus 1.3).",
"   </p>",
"   <p>",
"    Although patients with coronary disease are more likely to have a myocardial infarction at the time they are participating in strenuous exercise than when they are not, patients with coronary disease who exercise are overall less likely to have an MI than those with coronary disease who do not exercise. A 12 year prospective study of 2400 men found that men who were in the highest third of vigorous physical activity, compared to the lowest third, experienced a decreased risk of myocardial infarction, regardless of the presence of symptomatic, asymptomatic (EKG changes consistent with ischemia), or no coronary heart disease at baseline (HR 0.71, 0.42, and 0.60, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Rhabdomyolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subclinical myoglobinemia, myoglobinuria, and elevation of creatine kinase (CK) are common following physical exertion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/59\">",
"     59",
"    </a>",
"    ]. The CK level can rise several fold, particularly after intense exercise for extended periods of time (eg, marathon running). Rhabdomyolysis may occur following extreme exertion in individuals with normal muscles when the energy supply to muscle is insufficient to meet demands. Severe complications of rhabdomyolysis include renal failure, electrolyte abnormalities (eg, hyperkalemia, metabolic acidosis), and compartment syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Massive rhabdomyolysis may arise with marked physical exertion, particularly when the following risk factors are present [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The individual is physically untrained.",
"     </li>",
"     <li>",
"      Exertion occurs in extremely hot, humid conditions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16007?source=see_link\">",
"       \"Severe hyperthermia (heat stroke) in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Normal heat loss through sweating is impaired, such as via the use of anticholinergic medications or heavy football equipment.",
"     </li>",
"     <li>",
"      An individual with a sickle cell syndrome exercises at high altitude, a setting in which the decreased partial pressure of oxygen causes erythrocyte sickling with subsequent vascular occlusion and muscle ischemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=see_link\">",
"       \"Variant sickle cell syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Electrolytes abnormalities are present, particularly hypokalemia, which can be partly caused by potassium loss from sweating. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/33/10777?source=see_link&amp;anchor=H31734850#H31734850\">",
"       \"Causes of rhabdomyolysis\", section on 'Electrolyte disorders'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metabolic or inflammatory myopathies are present. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/56/905?source=see_link\">",
"       \"Approach to the metabolic myopathies\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"       \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, rhabdomyolysis can also occur in trained individuals following physical exertion in the absence of these risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Bronchoconstriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise-induced bronchoconstriction occurs in the majority of patients with current symptomatic asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/64\">",
"     64",
"    </a>",
"    ]. The magnitude of exercise-induced bronchoconstriction is correlated with the degree of airway hyperresponsiveness.",
"   </p>",
"   <p>",
"    Improving a patient&rsquo;s cardiovascular fitness reduces the minute ventilation required for a given level of exercise, thereby decreasing the stimulus for bronchoconstriction. Thus, regular, long-term exercise may be helpful in preventing the onset of exercise-induced bronchoconstriction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1513?source=see_link\">",
"     \"Exercise-induced bronchoconstriction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Other effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthermia, hypothermia, and dehydration are potential preventable risks of physical activity. Heat-related risks range from mild fatigue to death [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/65\">",
"     65",
"    </a>",
"    ]. Dehydration may be a problem itself or can be related to hyperthermia.",
"   </p>",
"   <p>",
"    Intense exercise can lead to amenorrhea and infertility, particularly in women with low body weight. The \"female athlete triad\" consists of disordered eating, amenorrhea, and osteoporosis. This is commonly seen in younger individuals, especially those who exercise regularly and intensely. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36919?source=see_link\">",
"     \"Amenorrhea and infertility associated with exercise\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Urticaria and anaphylaxis can rarely occur with exercise. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26777?source=see_link\">",
"     \"Exercise-induced anaphylaxis: Clinical manifestations, epidemiology, pathogenesis, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Exercise-associated hyponatremia primarily occurs in athletes participating in aerobic (endurance) events, such as marathons (42.2 km), triathlons (3.8 km swim, 180 km cycling, and 42.2 km running), and ultradistance (100 km) races. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1706?source=see_link\">",
"     \"Exercise-associated hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     MEDICAL EVALUATION PRIOR TO EXERCISE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical evaluation prior to initiation of an exercise program focuses on risks for coronary heart disease and other potential medical comorbidities that might place the patient at risk for one of the complications above.",
"   </p>",
"   <p>",
"    There is general consensus based on large observational studies that a screening medical evaluation prior to exercise is not necessary for asymptomatic patients at low risk for coronary heart disease. As an example, the Lipid Research Clinics Coronary Primary Prevention Trial found that, of 3617 asymptomatic men with hypercholesterolemia, the cumulative incidence of activity-related acute cardiac events was only 2 percent during a mean follow-up of 7.4 years [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/66\">",
"     66",
"    </a>",
"    ]. Furthermore, although the risk of a cardiac event was increased 2.6-fold in patients with clinically silent, exercise induced ST-segment changes during submaximal exercise ECG testing at study entry, only 11 of the 62 men who experienced an activity-related event had a positive test at entry (sensitivity 18 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=see_link&amp;anchor=H9#H9\">",
"     \"Screening for coronary heart disease\", section on 'Before an exercise program'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, there may be certain groups in which screening is warranted. Although the available data are not strong enough to reach consensus on the identity of these special groups, many clinicians perform periodic exercise ECG tests in asymptomatic individuals with multiple cardiovascular risk factors including hypercholesterolemia, hypertension, smoking, diabetes, and a history of premature myocardial infarction or sudden cardiac death in a first-degree relative under age 60. A positive exercise ECG test in such patients is associated with an increased risk of subsequent myocardial infarction and death. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=see_link&amp;anchor=H10#H10\">",
"     \"Screening for coronary heart disease\", section on 'High-risk patients'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When the decision is made to screen for coronary heart disease, no single test is ideal. However, it seems reasonable to conclude, based upon the available data, easy accessibility, and cost considerations, that initial screening with exercise ECG testing is the most prudent approach in high-risk individuals who can exercise and who do not have ECG abnormalities that can limit the detection of ischemic changes.",
"   </p>",
"   <p>",
"    In addition to determining whether testing should be performed to evaluate for coronary heart disease, the preexercise medical evaluation should attempt to identify other risks for the individual. Factors that may influence risk of injury include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age",
"     </li>",
"     <li>",
"      General physical condition",
"     </li>",
"     <li>",
"      Exercise history",
"     </li>",
"     <li>",
"      Orthopedic history and musculoskeletal risks",
"     </li>",
"     <li>",
"      Medication use (eg, beta blockers, calcium channel blockers, digitalis, nitrates, sulfonylureas, and insulin)",
"     </li>",
"     <li>",
"      History of pulmonary disease",
"     </li>",
"     <li>",
"      Anticipated type of exercise",
"     </li>",
"     <li>",
"      Handicaps or disabilities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical encounter provides an opportunity to counsel with respect to the goals of exercise, the importance of establishing and maintaining lifelong physical activity patterns, and to assess the degree of social support such as an exercise group, exercising peers, or family members.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     EXERCISE PRESCRIPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no one exercise prescription for all individuals. A general weekly goal of at least 150 minutes of moderate intensity aerobic activity or 75 minutes of vigorous intensity activity is ideal for many people. As sedentary lifestyles are associated with health risks and even modest increases in physical activity are associated with improved health outcomes, it is also reasonable to advocate for a modest increase in physical activity even if the specific goals above are not met. An individualized approach should be applied toward a specific exercise prescription, injury prevention, and maximizing incentives for maintaining a consistent exercise regimen. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Benefits of exercise'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H677890\">",
"    <span class=\"h2\">",
"     Exercise parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several factors are important in considering a specific exercise prescription. These include type of exercise, intensity, frequency, location, and markers indicating adequate degree of exercise during a given workout.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H428231382\">",
"    <span class=\"h3\">",
"     Types of exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a wide range of physical activities is available to patients, there are few data demonstrating superiority of one activity over another that would lead to substantially greater health benefits. Patients should select activities or sports that they enjoy to maximize likelihood of continued physical activity. Examples of common lifestyle exercises are brisk walking at 4.8 to 6.4 kilometers (three to four miles) per hour for most healthy adults, active yard work, and dancing. Exercises such as bicycling, jogging, and other leisure sports can also be performed (",
"    <a class=\"graphic graphic_table graphicRef66344 \" href=\"UTD.htm?36/56/37774\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Resistance (strength) training appears to add to the benefits of aerobic (endurance) training for cardiovascular fitness (",
"    <a class=\"graphic graphic_table graphicRef75107 \" href=\"UTD.htm?33/13/34012\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Deciding which type of exercise to recommend may depend on the setting in which the individual engages in exercise. A more structured environment with classes (eg, yoga, pilates, dancing) or in a fitness center (with a trainer or specialized equipment) may provide of variety of activities that may engage the individual, but home-based exercise (eg, jogging, using an exercise bike) may result in better adherence given low cost and convenience. Data are lacking in determining the optimal setting to perform exercise (eg, outdoors versus indoors, home versus fitness center) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. A systematic review of six trials evaluated the efficacy of home-based versus hospital (center)-based exercise programs in older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/68\">",
"     68",
"    </a>",
"    ]. In the short-term, center-based programs were superior to home-based programs in patients with peripheral vascular disease. However, in the long-term, home-based programs were superior to center-based programs in terms of adherence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H428231389\">",
"    <span class=\"h3\">",
"     Intensity and frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several large cohort studies have found that increasing exercise intensity is associated with a reduction in cardiovascular disease and all-cause mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/23,25,69\">",
"     23,25,69",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Benefits of exercise'",
"    </a>",
"    above.) Most guidelines recommend moderate to vigorous exercise intensity at least a few times per week [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2,70\">",
"     2,70",
"    </a>",
"    ]. However, the intensity and frequency of an exercise prescription varies based on a given individual.",
"   </p>",
"   <p>",
"    One of the most important parameters of exercise is total aerobic activity. A key finding of the 2008 Physical Activity Guidelines for Americans, based on a systematic review of the evidence, was that 500 to 1000 MET-minutes per week was the necessary amount of physical activity to produce substantial health benefits, including a substantial reduction in the risk of premature death and breast cancer (",
"    <a class=\"graphic graphic_figure graphicRef74679 \" href=\"UTD.htm?20/49/21277\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2\">",
"     2",
"    </a>",
"    ]. As the term METs (metabolic equivalents) is not readily understandable by many patients, these guidelines recommend the equivalent in minutes of moderate",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vigorous exercise per week. As an example, 150 minutes of walking (3.3 METs) per week is equal to 500 MET-minutes per week and meets the weekly recommendations for exercise in most individuals.",
"   </p>",
"   <p>",
"    Higher intensity activity may lead to additional gains in aerobic fitness. As an example, high-intensity interval walking (repeated alternating three minute sets of high and low intensity walking), compared to moderate-intensity continuous walking, resulted in greater improvements in blood pressure and muscle strength in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/71\">",
"     71",
"    </a>",
"    ]. Another popular form of exercise is high-intensity interval training, which involves repeated, brief sessions of high-intensity exercise over short periods of time. Although there is no standard regimen, one program for high-intensity interval training includes 30 seconds of &ldquo;all-out&rdquo; effort cycling or running repeated four to six times and separated by four minutes of recovery for a total of two to three minutes of intense training weekly for several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/72\">",
"     72",
"    </a>",
"    ]. High-intensity interval training is found to have several short-term physiologic benefits, including improved cardiorespiratory fitness [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/73\">",
"     73",
"    </a>",
"    ]. However, the long-term health effects of high-intensity interval training are not known. The potential for greater compliance and duration of exercise with moderate activity and increased injury with high intensity exercise should be factored in to determining an appropriate exercise prescription.",
"   </p>",
"   <p>",
"    A sedentary person should begin physical activity with short duration of low- or moderate-intensity activity and gradually increase the duration and intensity until the goal is reached. The greatest health benefits appear to be in those who move from sedentary to moderate-level activity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/74\">",
"     74",
"    </a>",
"    ]. Exercise can be performed for short periods several times a day and integrated into the course of one's daily life. In one randomized trial of previously sedentary healthy adults, subjects who engaged in 30 minutes of moderate-intensity physical activity on most days of the week had similar cardiovascular and blood pressure benefits as those who underwent a structured exercise program involving three or more sessions of supervised vigorous physical activity per week [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/75\">",
"     75",
"    </a>",
"    ]. In one large prospective cohort study, individuals who engaged in brief physical activity (15 minutes daily or 90 minutes weekly) had a 14 percent reduction in all-cause mortality and a three year longer life expectancy compared to those who were inactive [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/27\">",
"     27",
"    </a>",
"    ]. Using less vigorous recommendations for exercise may help more patients increase their activity level and accrue health benefits.",
"   </p>",
"   <p>",
"    Resistance training can supplement aerobic exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/76\">",
"     76",
"    </a>",
"    ]. One common regimen includes free weights or exercise equipment consisting of 10 to 15 repetitions of each exercise for arms, shoulders, chest, trunk, back, hips, and legs performed two to three times a week.",
"   </p>",
"   <p>",
"    Markers indicating an adequate degree of exercise include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Breathlessness",
"     </li>",
"     <li>",
"      Fatigue",
"     </li>",
"     <li>",
"      Sweating",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Achievement of goal heart rate is",
"    <strong>",
"     not",
"    </strong>",
"    necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/77\">",
"     77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link&amp;anchor=H20#H20\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\", section on 'The exercise prescription'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several national and international guidelines have similar goals of exercise intensity and frequency. The World Health Organization and the 2008 Physical Activity Guidelines for Americans recommend at least 150 minutes of moderate intensity aerobic activity or 75 minutes of vigorous intensity activity weekly for all adults [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/2,70\">",
"     2,70",
"    </a>",
"    ]. Patients with sedentary lifestyles should start with small amounts of physical activity and gradually increase duration, frequency, and intensity over time. Adults with poor mobility should stay as physically active as their condition allows and, if possible, perform physical activity to enhance balance and prevent falls on three or more days weekly. Muscle-strengthening activities that involve major muscle groups should be done on two or more days a week to provide additional benefit. Guidelines from the American Heart Association and the American College of Sports Medicine are similar, recommending either moderate intensity exercise for 30 minutes for a minimum of five days a week, or strenuous exercise for 20 minutes three days a week, or a combination of these activities [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/78\">",
"     78",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H263834579\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the benefits of an exercise program, there are risks as noted above, even in trained athletes. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Risks of exercise'",
"    </a>",
"    above.) As a result, the American Heart Association (AHA) published a summary outlining the absolute and relative contraindications for exercise testing and training (",
"    <a class=\"graphic graphic_table graphicRef80110 \" href=\"UTD.htm?16/11/16572\">",
"     table 5",
"    </a>",
"    ). The absolute contraindications include severe cardiac disease (eg, unstable angina, uncontrolled symptomatic heart failure) and acute noncardiac disease (eg, infection, renal failure). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H677157\">",
"    <span class=\"h2\">",
"     Injury prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no clear data that indicate which physical activities or sports are safest, nor what degree of activity is optimal to prevent injury. Recommendations for injury prevention should be tailored to specific populations. As an example, older populations may be at risk for falls. As the older population may injure more easily and recover more slowly, some patients will need to have supervised exercise. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=see_link\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Strategies to reduce running injuries are discussed separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Stretching",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies and randomized trials have found conflicting results on whether stretching prior to exercise is helpful for preventing injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/79-81\">",
"     79-81",
"    </a>",
"    ]. Systematic reviews have found that muscle stretching does not reduce delayed-onset muscle soreness after exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/82,83\">",
"     82,83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is little downside to the warm-up, and we still believe it is reasonable to recommend it prior to exercise. The warm-up can include stretching exercises, walking, or calisthenics; a period of five minutes should be adequate. Stretching exercises should be a slow dynamic movement followed by static stretch that is sustained for approximately 30 seconds. There should be no bouncing into the stretch or during the stretch.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Cool-down",
"    </span>",
"    &nbsp;&mdash;&nbsp;\"Cool-down\" after exercise for a period of approximately five minutes may facilitate lactate removal from muscles, the slow return from vasodilation, and gradual return of blood to the central circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/84\">",
"     84",
"    </a>",
"    ]. Cooling down leads to an increase in cardiac vagal tone and a reduction in resting heart rate, compared to complete rest without cool-down [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/85\">",
"     85",
"    </a>",
"    ]. The cool-down exercises may include slow walking, calisthenics, or stretching exercises.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Maximizing incentives",
"    </span>",
"    &nbsp;&mdash;&nbsp;The individual should perceive a net health benefit from his or her physical activity. The activity should be enjoyable and the person should feel both competent and safe while active. The activity should be readily accessible on a regular basis, and it should fit easily into the individual's daily schedule. The activity should not generate unbearable financial or social costs. Parents, other family members, and peers can provide a positive influence for initiating and maintaining physical activity.",
"   </p>",
"   <p>",
"    Physical activity in childhood predicts a continued active lifestyle into and through adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/86\">",
"     86",
"    </a>",
"    ]. Physically active parents can serve as role models for their children. Schools are also a major community resource to foster increased physical activity and promote a physically active lifestyle in children.",
"   </p>",
"   <p>",
"    The use of a pedometer may help motivate individuals to increase physical activity. A systematic review found that use of a pedometer worn throughout the day, combined with a specific goal for number of steps taken per day, increased physical activity by 27 percent, and was associated with modest decline in body mass index and blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Efficacy of exercise counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several systematic reviews have evaluated whether exercise counseling impacts levels of physical activity or secondary outcomes of increased activity (eg, physical fitness or metabolic parameters). Results have mostly supported some effectiveness for increasing self-reported activity levels, but less impact on more objective outcomes. Results of these systematic reviews include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2012 systematic review of randomized trials of primary care promotion of physical activity for sedentary individuals found a small to medium positive effect on self-reported increased activity over 12 months and a nonsignificant positive effect on cardiorespiratory fitness (odds ratio [OR] 1.38, 95% CI 0.98-1.95) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/88\">",
"       88",
"      </a>",
"      ]. The number needed to treat with an intervention for one additional sedentary adult to achieve recommended minimal levels of activity at 12 months was 12 (7 to 33).",
"     </li>",
"     <li>",
"      An updated 2010 systematic review for the United States Preventive Services Task Force (USPSTF) reviewed trials of counseling for exercise",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dietary change and found that moderate to intensive counseling was associated with small improvements in secondary outcomes (weight, blood pressure, lipids) and self-reported physical activity [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/89\">",
"       89",
"      </a>",
"      ]. Effective interventions were delivered by trained health educators (nutritionists, nurses, or exercise physiologists) and not by primary care clinicians.",
"     </li>",
"     <li>",
"      A 2007 systematic review of randomized and non-randomized studies found that counseling targeted to motivated sedentary patients, and tailored to patient's needs, could increase walking up to 30 to 60 minutes weekly at short-term follow-up (6 weeks to 12 months) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/90\">",
"       90",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 2005 systematic review that included only randomized studies with a minimum follow-up of six months found that interventions aimed at increasing physical activity had a moderate impact on self-reported activity (standardized mean difference 0.31, 95% CI 0.12-0.50), but achievement of predetermined goal levels of activity did not meet statistical significance [",
"      <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1990426\">",
"    <span class=\"h2\">",
"     Recommendations to promote physical activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The United States Preventive Services Task Force (USPSTF) revised earlier recommendations in 2012 and recommends that primary care clinicians may choose to selectively counsel patients to promote a healthful diet and physical activity, targeting patients with increased risk for CVD who exhibit readiness to change and for whom support is available to promote lifestyle changes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/92\">",
"     92",
"    </a>",
"    ]. This recommendation is based upon the small benefit observed from counseling in the primary care setting, and the time involved in providing the counseling that may otherwise be used to provide services of greater benefit. Nevertheless, the potential health benefits of even modest increases in exercise suggest that counseling to increase physical activity is likely warranted. More intensive, individualized counseling with scheduled follow-up may be effective [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/89,93\">",
"     89,93",
"    </a>",
"    ], including a personalized exercise prescription from primary care clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/94\">",
"     94",
"    </a>",
"    ] or through an exercise referral program [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/95\">",
"     95",
"    </a>",
"    ]. The American Heart Association prepared a listing of the most effective strategies to promote exercise, as well as healthy diet, based on a systematic review of studies published between 1999 and 2009 (",
"    <a class=\"graphic graphic_table graphicRef59899 \" href=\"UTD.htm?20/23/20861\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/96\">",
"     96",
"    </a>",
"    ]. The American Heart Association also prepared a set of population-based strategies to promote physical activity, as well as diet and smoking cessation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/46/28394/abstract/97\">",
"     97",
"    </a>",
"    ]. For physical activity, strategies include prompts to encourage use of stairs, incentives to commute by active means, increased opportunities, structured programs, and time set aside for physical activity in the school and workplace.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/39/20083?source=see_link\">",
"       \"Patient information: Exercise (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/22/9571?source=see_link\">",
"       \"Patient information: Arthritis and exercise (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/59/22450?source=see_link\">",
"       \"Patient information: Rhabdomyolysis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/42/7844?source=see_link\">",
"       \"Patient information: Exercise (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"       \"Patient information: Arthritis and exercise (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical inactivity is a major health problem worldwide, particularly in developed countries and among women, older persons, and those with lower incomes. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Physical inactivity as a global health problem'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Moderate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vigorous exercise is associated with several beneficial health outcomes, including a decreased risk of obesity, coronary heart disease, stroke, certain types of cancer, and all-cause mortality (",
"      <a class=\"graphic graphic_table graphicRef51565 \" href=\"UTD.htm?10/2/10283\">",
"       table 1",
"      </a>",
"      ). Exercise may also increase the likelihood of stopping tobacco use; reduce disability for activities of daily living in older persons; delay cognitive decline in older adults; and reduce stress, anxiety, and depression. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Benefits of exercise'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Musculoskeletal injury is the most common risk of exercise. More serious, but less common, risks include arrhythmia, sudden cardiac arrest, and myocardial infarction. However, the benefits of exercise outweigh the potential risks. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Risks of exercise'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A screening medical evaluation for coronary heart disease prior to starting exercise is not necessary for asymptomatic, low-risk patients. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Medical evaluation prior to exercise'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=see_link\">",
"       \"Screening for coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that all healthy adults incorporate moderate to vigorous exercise into their lifestyle (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). One option is moderate intensity exercise for 150 minutes a week, vigorous intensity exercise for 75 minutes a week, or an equivalent combination of these activities. Adults with limited exercise capacity due to comorbidity should stay as physically active as their condition allows. Even modest increases in exercise are associated with health benefits. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Exercise prescription'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The effectiveness of counseling for exercise has not been demonstrated. However, the potential health benefits of exercise suggest that clinicians should counsel patients to increase physical activity on a case-by-case basis. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Exercise prescription'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/1\">",
"      Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009; 301:2024.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. 2008 physical activity guidelines for Americans. Hyattsville, MD: US Department of Health and Human Services 2008. Available at: www.health.gov/PAGuidelines/guidelines/default.aspx (Accessed on October 17, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/3\">",
"      Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273:402.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/5\">",
"      Proper KI, Singh AS, van Mechelen W, Chinapaw MJ. Sedentary behaviors and health outcomes among adults: a systematic review of prospective studies. Am J Prev Med 2011; 40:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/6\">",
"      Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/7\">",
"      Dumith SC, Hallal PC, Reis RS, Kohl HW 3rd. Worldwide prevalence of physical inactivity and its association with human development index in 76 countries. Prev Med 2011; 53:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/8\">",
"      Owen N, Sparling PB, Healy GN, et al. Sedentary behavior: emerging evidence for a new health risk. Mayo Clin Proc 2010; 85:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/9\">",
"      Rey-L&oacute;pez JP, Vicente-Rodriguez G, Ortega FB, et al. Sedentary patterns and media availability in European adolescents: The HELENA study. Prev Med 2010; 51:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/10\">",
"      Matthews CE, Chen KY, Freedson PS, et al. Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am J Epidemiol 2008; 167:875.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Contr9ol and Prevention, National Health and Nutrition Examination Survey Data, 2005-2006. file://www.cdc.gov/nchs/nhanes.htm.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/12\">",
"      Carlson SA, Fulton JE, Schoenborn CA, Loustalot F. Trend and prevalence estimates based on the 2008 Physical Activity Guidelines for Americans. Am J Prev Med 2010; 39:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/13\">",
"      Centers for Disease Control and Prevention (CDC). Contribution of occupational physical activity toward meeting recommended physical activity guidelines: United States, 2007. MMWR Morb Mortal Wkly Rep 2011; 60:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/14\">",
"      van der Ploeg HP, Chey T, Korda RJ, et al. Sitting time and all-cause mortality risk in 222 497 Australian adults. Arch Intern Med 2012; 172:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/15\">",
"      Gupta S, Rohatgi A, Ayers CR, et al. Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation 2011; 123:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/16\">",
"      Wee CC, McCarthy EP, Davis RB, Phillips RS. Physician counseling about exercise. JAMA 1999; 282:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/17\">",
"      Eakin E, Brown W, Schofield G, et al. General practitioner advice on physical activity--who gets it? Am J Health Promot 2007; 21:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/18\">",
"      Croteau K, Schofield G, McLean G. Physical activity advice in the primary care setting: results of a population study in New Zealand. Aust N Z J Public Health 2006; 30:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/19\">",
"      Willis BL, Gao A, Leonard D, et al. Midlife fitness and the development of chronic conditions in later life. Arch Intern Med 2012; 172:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/20\">",
"      Andersen LB, Schnohr P, Schroll M, Hein HO. All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work. Arch Intern Med 2000; 160:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/21\">",
"      Paffenbarger RS Jr, Hyde RT, Wing AL, et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/22\">",
"      Gregg EW, Cauley JA, Stone K, et al. Relationship of changes in physical activity and mortality among older women. JAMA 2003; 289:2379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/23\">",
"      Leitzmann MF, Park Y, Blair A, et al. Physical activity recommendations and decreased risk of mortality. Arch Intern Med 2007; 167:2453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/24\">",
"      Manson JE, Hu FB, Rich-Edwards JW, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 1999; 341:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/25\">",
"      Franco OH, de Laet C, Peeters A, et al. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med 2005; 165:2355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/26\">",
"      Manini TM, Everhart JE, Patel KV, et al. Daily activity energy expenditure and mortality among older adults. JAMA 2006; 296:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/27\">",
"      Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 2011; 378:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/28\">",
"      Wessel TR, Arant CB, Olson MB, et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA 2004; 292:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/29\">",
"      Myers J, Kaykha A, George S, et al. Fitness versus physical activity patterns in predicting mortality in men. Am J Med 2004; 117:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/30\">",
"      Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/31\">",
"      Hamer M, Sabia S, Batty GD, et al. Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study. Circulation 2012; 126:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/32\">",
"      Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010; 40:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/33\">",
"      Wendel-Vos GC, Schuit AJ, Feskens EJ, et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol 2004; 33:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/34\">",
"      Michaud DS, Giovannucci E, Willett WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/35\">",
"      Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012; 62:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/36\">",
"      Wolin KY, Yan Y, Colditz GA, Lee IM. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 2009; 100:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/37\">",
"      Boyle T, Keegel T, Bull F, et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst 2012; 104:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/38\">",
"      Irwin ML, Yasui Y, Ulrich CM, et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA 2003; 289:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/39\">",
"      Slentz CA, Duscha BD, Johnson JL, et al. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE--a randomized controlled study. Arch Intern Med 2004; 164:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/40\">",
"      Hankinson AL, Daviglus ML, Bouchard C, et al. Maintaining a high physical activity level over 20 years and weight gain. JAMA 2010; 304:2603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/41\">",
"      Lee IM, Djouss&eacute; L, Sesso HD, et al. Physical activity and weight gain prevention. JAMA 2010; 303:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/42\">",
"      Marcus BH, Albrecht AE, King TK, et al. The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial. Arch Intern Med 1999; 159:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/43\">",
"      Herring MP, O'Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med 2010; 170:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/44\">",
"      Martin CK, Church TS, Thompson AM, et al. Exercise dose and quality of life: a randomized controlled trial. Arch Intern Med 2009; 169:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/45\">",
"      Bouchard C, Blair SN, Church TS, et al. Adverse metabolic response to regular exercise: is it a rare or common occurrence? PLoS One 2012; 7:e37887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/46\">",
"      Conn JM, Annest JL, Gilchrist J. Sports and recreation related injury episodes in the US population, 1997-99. Inj Prev 2003; 9:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/47\">",
"      Falvey EC, Eustace J, Whelan B, et al. Sport and recreation-related injuries and fracture occurrence among emergency department attendees: implications for exercise prescription and injury prevention. Emerg Med J 2009; 26:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/48\">",
"      Diener-Martin E, Bruegger O, Martin B. Physical activity promotion and safety prevention: what is the relationship in different population groups? Br J Sports Med 2011; 45:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/49\">",
"      Burns J, Keenan AM, Redmond AC. Factors associated with triathlon-related overuse injuries. J Orthop Sports Phys Ther 2003; 33:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/50\">",
"      Wen DY. Risk factors for overuse injuries in runners. Curr Sports Med Rep 2007; 6:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/51\">",
"      Corrado D, Migliore F, Basso C, Thiene G. Exercise and the risk of sudden cardiac death. Herz 2006; 31:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/52\">",
"      Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. JAMA 2011; 305:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/53\">",
"      Albert CM, Mittleman MA, Chae CU, et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/54\">",
"      Whang W, Manson JE, Hu FB, et al. Physical exertion, exercise, and sudden cardiac death in women. JAMA 2006; 295:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/55\">",
"      Cheitlin MD, MacGregor J. Congenital anomalies of coronary arteries: role in the pathogenesis of sudden cardiac death. Herz 2009; 34:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/56\">",
"      Thompson PD, Franklin BA, Balady GJ, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007; 115:2358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/57\">",
"      Willich SN, Lewis M, L&ouml;wel H, et al. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 1993; 329:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/58\">",
"      Yu S, Patterson CC, Yarnell JW. Is vigorous physical activity contraindicated in subjects with coronary heart disease? Evidence from the Caerphilly study. Eur Heart J 2008; 29:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/59\">",
"      Sayers SP, Clarkson PM. Exercise-induced rhabdomyolysis. Curr Sports Med Rep 2002; 1:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/60\">",
"      Santos J Jr. Exertional rhabdomyolysis. Potentially life-threatening consequence of intense exercise. JAAPA 1999; 12:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/61\">",
"      Guron G, Marcussen N, Friberg P. Urinary acidification and net acid excretion in adult rats treated neonatally with enalapril. Am J Physiol 1998; 274:R1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/62\">",
"      Lonka L, Pedersen RS. Fatal rhabdomyolysis in marathon runner. Lancet 1987; 1:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/63\">",
"      Alpers JP, Jones LK Jr. Natural history of exertional rhabdomyolysis: a population-based analysis. Muscle Nerve 2010; 42:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/64\">",
"      Randolph C. An update on exercise-induced bronchoconstriction with and without asthma. Curr Allergy Asthma Rep 2009; 9:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/65\">",
"      P&eacute;riard JD, Caillaud C, Thompson MW. Central and peripheral fatigue during passive and exercise-induced hyperthermia. Med Sci Sports Exerc 2011; 43:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/66\">",
"      Siscovick DS, Ekelund LG, Johnson JL, et al. Sensitivity of exercise electrocardiography for acute cardiac events during moderate and strenuous physical activity. The Lipid Research Clinics Coronary Primary Prevention Trial. Arch Intern Med 1991; 151:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/67\">",
"      Foley A, Hillier S, Barnard R. Effectiveness of once-weekly gym-based exercise programmes for older adults post discharge from day rehabilitation: a randomised controlled trial. Br J Sports Med 2011; 45:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/68\">",
"      Ashworth NL, Chad KE, Harrison EL, et al. Home versus center based physical activity programs in older adults. Cochrane Database Syst Rev 2005; :CD004017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/69\">",
"      Wannamethee SG, Shaper AG, Alberti KG. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med 2000; 160:2108.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Global recommendations on physical activity for health. file://www.who.int/dietphysicalactivity/pa/en/index.html (Accessed on May 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/71\">",
"      Nemoto K, Gen-no H, Masuki S, et al. Effects of high-intensity interval walking training on physical fitness and blood pressure in middle-aged and older people. Mayo Clin Proc 2007; 82:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/72\">",
"      Gibala MJ, McGee SL. Metabolic adaptations to short-term high-intensity interval training: a little pain for a lot of gain? Exerc Sport Sci Rev 2008; 36:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/73\">",
"      Wisl&oslash;ff U, Ellingsen &Oslash;, Kemi OJ. High-intensity interval training to maximize cardiac benefits of exercise training? Exerc Sport Sci Rev 2009; 37:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/74\">",
"      Blair SN, Kohl HW 3rd, Barlow CE, et al. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995; 273:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/75\">",
"      Dunn AL, Marcus BH, Kampert JB, et al. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA 1999; 281:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/76\">",
"      Ciccolo JT, Pettee Gabriel KK, Macera C, Ainsworth BE. Association between self-reported resistance training and self-rated health in a national sample of U.S. men and women. J Phys Act Health 2010; 7:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/77\">",
"      Bosquet L, Merkari S, Arvisais D, Aubert AE. Is heart rate a convenient tool to monitor over-reaching? A systematic review of the literature. Br J Sports Med 2008; 42:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/78\">",
"      Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/79\">",
"      McHugh MP, Cosgrave CH. To stretch or not to stretch: the role of stretching in injury prevention and performance. Scand J Med Sci Sports 2010; 20:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/80\">",
"      Woods K, Bishop P, Jones E. Warm-up and stretching in the prevention of muscular injury. Sports Med 2007; 37:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/81\">",
"      Small K, Mc Naughton L, Matthews M. A systematic review into the efficacy of static stretching as part of a warm-up for the prevention of exercise-related injury. Res Sports Med 2008; 16:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/82\">",
"      Herbert RD, de Noronha M. Stretching to prevent or reduce muscle soreness after exercise. Cochrane Database Syst Rev 2007; :CD004577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/83\">",
"      Henschke N, Lin CC. Stretching before or after exercise does not reduce delayed-onset muscle soreness. Br J Sports Med 2011; 45:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/84\">",
"      American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998; 30:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/85\">",
"      Takahashi T, Okada A, Hayano J, Tamura T. Influence of cool-down exercise on autonomic control of heart rate during recovery from dynamic exercise. Front Med Biol Eng 2002; 11:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/86\">",
"      Salonen MK, Kajantie E, Osmond C, et al. Prenatal and childhood growth and leisure time physical activity in adult life. Eur J Public Health 2011; 21:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/87\">",
"      Bravata DM, Smith-Spangler C, Sundaram V, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007; 298:2296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/88\">",
"      Orrow G, Kinmonth AL, Sanderson S, Sutton S. Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials. BMJ 2012; 344:e1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/89\">",
"      Lin JS, O'Connor E, Whitlock EP, Beil TL. Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2010; 153:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/90\">",
"      Ogilvie D, Foster CE, Rothnie H, et al. Interventions to promote walking: systematic review. BMJ 2007; 334:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/91\">",
"      Hillsdon M, Foster C, Thorogood M. Interventions for promoting physical activity. Cochrane Database Syst Rev 2005; :CD003180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/92\">",
"      Moyer VA, U.S. Preventive Services Task Force. Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/93\">",
"      Lawton BA, Rose SB, Raina Elley C, et al. Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial. Br J Sports Med 2009; 43:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/94\">",
"      Grandes G, Sanchez A, Sanchez-Pinilla RO, et al. Effectiveness of physical activity advice and prescription by physicians in routine primary care: a cluster randomized trial. Arch Intern Med 2009; 169:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/95\">",
"      Pavey TG, Taylor AH, Fox KR, et al. Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. BMJ 2011; 343:d6462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/96\">",
"      Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 2010; 122:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/46/28394/abstract/97\">",
"      Mozaffarian D, Afshin A, Benowitz NL, et al. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation 2012; 126:1514.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2786 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-33503A3141-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28394=[""].join("\n");
var outline_f27_46_28394=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H38\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHYSICAL INACTIVITY AS A GLOBAL HEALTH PROBLEM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EXERCISE PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      BENEFITS OF EXERCISE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Cancer prevention and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H496083\">",
"      Osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Gallstones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Function and cognition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Psychological",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      RISKS OF EXERCISE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H677150\">",
"      Musculoskeletal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Bronchoconstriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Other effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      MEDICAL EVALUATION PRIOR TO EXERCISE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      EXERCISE PRESCRIPTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H677890\">",
"      Exercise parameters",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H428231382\">",
"      - Types of exercise",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H428231389\">",
"      - Intensity and frequency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H263834579\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H677157\">",
"      Injury prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Stretching",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Cool-down",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Maximizing incentives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Efficacy of exercise counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1990426\">",
"      Recommendations to promote physical activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2786\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2786|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/14/25824\" title=\"figure 1\">",
"      Moderate physical activities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/18/4398\" title=\"figure 2\">",
"      Lifestyle and survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/49/21277\" title=\"figure 3\">",
"      Declining risk of premature death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/55/29565\" title=\"figure 4\">",
"      Exercise and cardiac events",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2786|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/2/10283\" title=\"table 1\">",
"      Benefits physical activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/51/20284\" title=\"table 2\">",
"      Evidence health benefits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/56/37774\" title=\"table 3\">",
"      Energy spent with activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/13/34012\" title=\"table 4\">",
"      Exercise prescription",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/11/16572\" title=\"table 5\">",
"      Contraindications to exercise treadmill testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/23/20861\" title=\"table 6\">",
"      AHA recs for exercise and diet counseling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36919?source=related_link\">",
"      Amenorrhea and infertility associated with exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/56/905?source=related_link\">",
"      Approach to the metabolic myopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23192?source=related_link\">",
"      Arrhythmia in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=related_link\">",
"      C-reactive protein in cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27098?source=related_link\">",
"      Cancer-related fatigue: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/33/10777?source=related_link\">",
"      Causes of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/36/36424?source=related_link\">",
"      Clinical significance and treatment of ventricular premature beats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20265?source=related_link\">",
"      Effects of exercise in diabetes mellitus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17015?source=related_link\">",
"      Effects of exercise on lipoproteins and hemostatic factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=related_link\">",
"      Epidemiology of and risk factors for gallstones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29129?source=related_link\">",
"      Exercise ECG testing to determine prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/59/2998?source=related_link\">",
"      Exercise in the treatment and prevention of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=related_link\">",
"      Exercise physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1706?source=related_link\">",
"      Exercise-associated hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/9/26777?source=related_link\">",
"      Exercise-induced anaphylaxis: Clinical manifestations, epidemiology, pathogenesis, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1513?source=related_link\">",
"      Exercise-induced bronchoconstriction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44775?source=related_link\">",
"      Musculoskeletal injury in the young athlete: Overview of treatment principles for nonoperative injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14298?source=related_link\">",
"      Overview of physical activity and strength training in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34890?source=related_link\">",
"      Overview of running injuries of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=related_link\">",
"      Overview of sudden cardiac arrest and sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=related_link\">",
"      Patient information: Arthritis and exercise (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/22/9571?source=related_link\">",
"      Patient information: Arthritis and exercise (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/42/7844?source=related_link\">",
"      Patient information: Exercise (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/39/20083?source=related_link\">",
"      Patient information: Exercise (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/59/22450?source=related_link\">",
"      Patient information: Rhabdomyolysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=related_link\">",
"      Prediction and prevention of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41369?source=related_link\">",
"      Prevention of dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=related_link\">",
"      Prevention of falls and complications of falls in community-dwelling older persons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/21/33113?source=related_link\">",
"      Prevention of osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7657?source=related_link\">",
"      Recommendations for exercise during pregnancy and the postpartum period",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36202?source=related_link\">",
"      Risk factors for dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=related_link\">",
"      Risk of sudden cardiac death in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21144?source=related_link\">",
"      Role of physical activity and exercise in obese adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=related_link\">",
"      Screening for coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=related_link\">",
"      Secondary prevention of stroke: Risk factor reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16007?source=related_link\">",
"      Severe hyperthermia (heat stroke) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=related_link\">",
"      Smoking cessation counseling strategies in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43321?source=related_link\">",
"      The roles of diet, physical activity, and body weight in cancer survivorship",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5209?source=related_link\">",
"      Variant sickle cell syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_46_28395="Cytokines radiation exposure";
var content_f27_46_28395=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F66044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F66044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cytokine doses after radiation exposure",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Cytokine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adult dose*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Precautions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        G-CSF",
"       </td>",
"       <td>",
"        5 &micro;g/kg per day SQ until ANC",
"&gt;1000/microL",
"       </td>",
"       <td>",
"        Sickle cell disease, significant coronary art disease,",
"ARDS&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pegylated G-CSF",
"       </td>",
"       <td>",
"        6 mg SQ as a single dose",
"       </td>",
"       <td>",
"        as with G-CSF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GM-CSF",
"       </td>",
"       <td>",
"        250 &micro;g/m2/day SQ until ANC &gt;1000/microL",
"       </td>",
"       <td>",
"        as with G-CSF",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     G-CSF: granulocyte colony-stimulating factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; ARDS: acute respiratory distress syndrome; ANC: absolute neutrophil count.",
"     <br>",
"      * Recommended doses of G-CSF and GM-CSF are similar for adults, pregnant women, and children. Dose for pegylated G-CSF for adolescents &gt;45 kg is the same as that for adults.",
"      <br>",
"       &bull; Consider discontinuation of cytokines if pulmonary infiltrates develop at the time of neutrophil recovery.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Waselenko JK, MacVittie TJ, Blakely WF, et al. Medical management of the acute radiation syndrome: Recommendations of the strategic national stockpile radiation working group. Ann Int Med 2004; 140:1039. Copyright &copy; 2004 American College of Physicians.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28395=[""].join("\n");
var outline_f27_46_28395=null;
var title_f27_46_28396="Modified RECIST for hepatocellular carcinoma";
var content_f27_46_28396=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified RECIST for hepatocellular carcinoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Response assessment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Target lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CR",
"       </td>",
"       <td>",
"        Disappearance of all target lesions or disappearance of any intratumoral arterial enhancement in all target lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        PR",
"       </td>",
"       <td>",
"        At least 30 percent decrease in the sum of diameters of viable (enhancing) target lesions, taking as a reference the baseline sum of the diameters of target lesions*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        PD",
"       </td>",
"       <td>",
"        Any increase of at least 20 percent in the sum of the diameters of viable target lesions, taking as a reference the smallest sum of the diameters of viable (enhancing) target lesions recorded since treatment started*",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        SD",
"       </td>",
"       <td>",
"        Any cases that do not qualify for either partial response or progressive disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Non-target lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malignant portal vein thrombosis",
"       </td>",
"       <td>",
"        Should be considered a nonmeasurable lesion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymph nodes",
"       </td>",
"       <td>",
"        If detected at the porta hepatis, should be considered malignant if the short axis dimension is &ge;2.0 cm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pleural effusions and ascites",
"       </td>",
"       <td>",
"        Emergence of, or increase in, ascites is common during the course of treatment of a cirrhotic patient and may reflect worsening of the underlying chronic liver disease, and be unrelated to cancer progression. The same is true of pleural effusions. Cytopathologic confirmation of the neoplastic nature of any effusion that appears during treatment is required when the measurable tumor has met criteria for response or stable disease.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New lesions",
"       </td>",
"       <td>",
"        A newly detected hepatic nodule is classified as hepatocellular carcinoma (and declared evidence of progression) when its longest diameter is at least 1 cm and the nodule has a typical vascular pattern on dynamic imaging (hypervascular in arterial phase with washout in the portal venous or late venous phase). Liver lesions &gt;1 cm that do not show a typical vascular pattern can be diagnosed as hepatocellular carcinoma if there is at least 1 cm internal growth on subsequent scans.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     RECIST: Response Evaluation Criteria In Solid Tumors; CR: complete response; PR: partial response; PD: progressive disease: SD: stable disease.",
"     <br>",
"      * Enhancement in the arterial phase reflects viable tumor tissue.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Lencioni R, et al. Semin Liver Dis 2010: 30:52.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28396=[""].join("\n");
var outline_f27_46_28396=null;
var title_f27_46_28397="Relationship between age and arrhythmias in HCM";
var content_f27_46_28397=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The occurrence of arrhythmia in hypertrophic cardiomyopathy increases with age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 282px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In patients with hypertrophic cardiomyopathy, the prevalence of all arrhythmias, including atrial fibrillation (AF), supraventricular tachycardia (SVT), and ventricular tachycardia (VT) increases with age (St. George's Registry).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Perry Elliott, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28397=[""].join("\n");
var outline_f27_46_28397=null;
var title_f27_46_28398="Staying centered on values";
var content_f27_46_28398=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F81986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F81986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    The struggle to stay centered on values in the profession of medicine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 240px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Inui TS. A Flag in the Wind: Educating for Professionalism in Medicine. Association of American Medical Colleges, Washington, DC 2003. Copyright &copy; 2003 Association of American Medical Colleges.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_46_28398=[""].join("\n");
var outline_f27_46_28398=null;
var title_f27_46_28399="Contents: Antenatal care";
var content_f27_46_28399=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Antenatal care",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Antenatal care",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adaptations to pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/61/35798\">",
"           Androgen production and metabolism in normal pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/37/26198\">",
"           Approach to liver disease occurring during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/33/2584\">",
"           Calcium physiology in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/12/21703\">",
"           Hematologic changes in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/47/14073\">",
"           Hypothyroidism during pregnancy: Clinical manifestations, diagnosis, and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/22/36201\">",
"           Immunology of the maternal-fetal interface",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/40/20105\">",
"           Maternal cardiovascular and hemodynamic adaptations to pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/61/13274\">",
"           Maternal endocrine and metabolic adaptation to pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/60/9160\">",
"           Maternal gastrointestinal tract adaptation to pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/1/2074\">",
"           Musculoskeletal changes and pain during pregnancy and postpartum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/7/14454\">",
"           Normal reference ranges for laboratory values in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/51/16186\">",
"           Overview of thyroid disease in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/32/24072\">",
"           Renal and urinary tract physiology in normal pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/37/32340\">",
"           Respiratory tract changes during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/62/35816\">",
"           The skin, hair, nails, and mucous membranes during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/37/20056\">",
"           Work and pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diagnosis of pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/48/44808\">",
"           Clinical manifestations and diagnosis of early pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fetal assessment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/11/2232\">",
"           Antepartum fetal heart rate assessment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/52/31558\">",
"           Assessment of amniotic fluid volume",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/58/42919\">",
"           Assessment of fetal lung maturity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/41/5783\">",
"           Diagnosis and outcome of first trimester growth delay",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/30/10728\">",
"           Doppler ultrasound of the umbilical artery for fetal surveillance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/37/15959\">",
"           Evaluation of decreased fetal movements",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/7/23674\">",
"           Intrapartum fetal heart rate assessment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/13/25815\">",
"           Nuchal cords",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/26/30121\">",
"           Overview of fetal assessment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/47/34553\">",
"           Prenatal assessment of gestational age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/1/25\">",
"           Prenatal sonographic assessment of fetal weight",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/35/43576\">",
"           Routine prenatal ultrasonography as a screening tool",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11928\">",
"           The fetal biophysical profile",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36824\">",
"           Ultrasound examination in obstetrics and gynecology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/56/14217\">",
"           Venous Doppler for fetal assessment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Immunization",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/53/32602\">",
"           Immunizations during pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Newborn issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/46/41705\">",
"           Neonatal circumcision: Risks and benefits",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Prenatal care",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/29/4568\">",
"           Anatomical and physiological changes of pregnancy and exercise",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/57/19354\">",
"           Chemoprophylaxis for the prevention of neonatal group B streptococcal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/62/22503\">",
"           Cystic fibrosis: Prenatal genetic screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/7/31865\">",
"           Effect of advanced age on fertility and pregnancy in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/54/30567\">",
"           Effect of advanced paternal age on fertility and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/18/27945\">",
"           Fertility and pregnancy after bariatric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/13/7386\">",
"           Genetic and environmental causes of birth defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/49/11030\">",
"           Group prenatal care",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/1/42010\">",
"           Initial prenatal assessment and patient education",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/48/35590\">",
"           Management of infertility and pregnancy in women of advanced age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/44/28362\">",
"           Nutrition in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/9/17556\">",
"           Obstetrical issues in grand multiparity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/27/22969\">",
"           Overview of prenatal screening and diagnosis of Down syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/25/16794\">",
"           Preconception evaluation and counseling",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/31/10744\">",
"           Pregnancy in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/29/24023\">",
"           Pregnancy in homeless women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/48/44807\">",
"           Prenatal care (after initial prenatal assessment)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/39/632\">",
"           Prenatal care for incarcerated women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/35/25145\">",
"           Prenatal screening and diagnosis of neural tube defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/24/12681\">",
"           Prenatal screening for genetic disease in the Ashkenazi Jewish population",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/30/7657\">",
"           Recommendations for exercise during pregnancy and the postpartum period",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/31/33273\">",
"           Risks and benefits of fish consumption and fish oil supplements during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/35/43576\">",
"           Routine prenatal ultrasonography as a screening tool",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/35/20026\">",
"           The effects of caffeine on reproductive outcomes in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/11/29882\">",
"           The impact of obesity on fertility and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/33/21017\">",
"           Transvaginal ultrasound assessment of the cervix and prediction of spontaneous preterm birth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36824\">",
"           Ultrasound examination in obstetrics and gynecology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/54/19304\">",
"           Weight gain and loss in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Prenatal diagnosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/60/27592\">",
"           Basic principles and safety of diagnostic ultrasound in obstetrics and gynecology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/0/31751\">",
"           Basic principles of genetic counseling for the obstetrical provider",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/32/28169\">",
"           Chorionic villus sampling: Risks, complications, and techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/0/23562\">",
"           Congenital cytogenetic abnormalities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/62/22503\">",
"           Cystic fibrosis: Prenatal genetic screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/11/16570\">",
"           Diagnostic amniocentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/31/11768\">",
"           Fetal blood sampling",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/20/36166\">",
"           Fetal echogenic bowel",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/22/7529\">",
"           First trimester combined test and integrated tests for screening for Down syndrome and trisomy 18",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/50/2857\">",
"           First trimester cystic hygroma and increased nuchal translucency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/61/5081\">",
"           Folic acid for prevention of neural tube defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/39/27257\">",
"           Laboratory issues related to maternal serum screening for Down syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/52/42824\">",
"           Overview of antenatal hydronephrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/27/22969\">",
"           Overview of prenatal screening and diagnosis of Down syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/2/29736\">",
"           Parentage testing using DNA",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/57/18329\">",
"           Pregnancy outcomes predicted by serum markers assayed in Down syndrome screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/36/27210\">",
"           Prenatal diagnosis and obstetrical management of umbilical cord abnormalities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/44/2762\">",
"           Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/26/1448\">",
"           Prenatal diagnosis using cell-free fetal nucleic acids in maternal blood",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/54/23399\">",
"           Prenatal screening and diagnosis for fragile X syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/35/25145\">",
"           Prenatal screening and diagnosis of neural tube defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/24/12681\">",
"           Prenatal screening for genetic disease in the Ashkenazi Jewish population",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/28/34247\">",
"           Prenatal sonographic diagnosis of fetal abdominal wall defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/26/24999\">",
"           Prenatal testing for the hemoglobinopathies and thalassemias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/29/1493\">",
"           Second trimester maternal serum screening for Down syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/14/8423\">",
"           Single umbilical artery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/41/22170\">",
"           Sonographic findings associated with fetal aneuploidy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/46/35560\">",
"           Ultrasound diagnosis of neural tube defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/2/7208\">",
"           Use of array comparative genomic hybridization (aCGH) in obstetrics",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-B31D7ED545-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f27_46_28399=[""].join("\n");
var outline_f27_46_28399=null;
          